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Nanoparticles (NPs) have become a key tool in medicine and biotechnology; as drug
delivery systems, biosensors, and diagnostic devices. However, the mechanism of biocorona
formation on nanoparticle surfaces and their impact on drug delivery remains speculative.
Nevertheless, functionalized nanoparticles have demonstrated major success in medical
applications; having been shown to effectively treat disease.
The mechanistic details of protein behavior on nanoparticle surfaces remain poorly
understood to date; due to difficulty in determining the orientation and structure of protein on
NPs. Furthermore, surface crowding, orientation, and degree of disorder have been shown to
perturb the efficacy of protein on NPs; dramatically reducing their benefits. NMR and other
biophysical tools can be used to characterize the nanoparticle-protein surface interactions;
leading to a better understanding of the biocorona structure.
This dissertation investigates the structure, orientation, and function of proteins adsorbed
on gold nanoparticles (P-AuNPs). Using hydrogen-deuterium exchange and methylation studies
on P-AuNPs, we have elucidated the structure and orientation of proteins on AuNP surfaces. We
have also designed fusion proteins that can effectively mitigate structural-, orientation-, and

activity-perturbations of P-AuNPs. The benefits of our fusion protein approach have been
verified via enzymatic assay; which monitored the enzymatic activity of these P-AuNPs.
Bioﬁlms are defined as surface-anchored, multi-cellular, three-dimensional, bacterial
communities. Biofilms have a serious impact on public health; because of their role in infectious
diseases and medical device-related infections. S. epidermidis is the most common biofilmforming bacteria. Therefore, understanding the mechanisms of biofilm formation could lead to
novel therapeutics which prevent biofilm formation. One of the most recognized proteins in the
biofilm formation mechanism is the S. epidermidis autolysin domain. Therefore, we have studied
the structure and behavior of S. epidermidis autolysin repeat domain R2 (R2ab) via solution
NMR and other biophysical techniques. This study has provided a deeper understanding of how
R2ab interacts with foreign surfaces and blood proteins; which could lead to future methods of
biofilm prevention.
Over the course of this dissertation, the characterization of protein-surface interactions
was achieved via solution NMR and other biophysical tools; providing insightful information to
the fields of medicine and therapeutics.
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CHAPTER I
PROTEIN INTERACTIONS WITH NANOPARTICLE SURFACES: HIGHLIGHTING
SOLUTION NMR TECHNIQUES
Reprinted with permission from Perera, Y. Randika, et al. " Protein Interactions with
Nanoparticle Surfaces: Highlighting Solution NMR Techniques." Israel Journal of Chemistry.
Copyright (2020) American Chemical Society.

“Curiosity and the urge to solve problems are the emotional hallmarks of our species.”
-Carl Sagan

1.1

Abstract
In the last decade, nanoparticles (NPs) have become a key tool in medicine and

biotechnology as drug delivery systems, biosensors and diagnostic devices. The composition and
surface chemistry of NPs vary based on the materials used: typically, organic polymers,
inorganic materials, or lipids. Nanoparticle classes can be further divided into sub-categories
depending on the surface modification and functionalization. These surface properties matter
when NPs are introduced into a physiological environment, as they will influence how nucleic
acids, lipids, and proteins will interact with the NP surface. While small-molecule interactions
are easily probed using NMR spectroscopy, studying protein-NP interactions using NMR
1

introduces several challenges. For example, globular proteins may have a perturbed
conformation when attached to a foreign surface, and the size of NP-protein conjugates can lead
to excessive line broadening. Many of these challenges have been addressed, and NMR
spectroscopy is becoming a mature technique for in situ analysis of NP binding behavior. It is
therefore not surprising that NMR has been applied to NP systems and has been used to study
biomolecules on NP surfaces. Important considerations include corona composition, protein
behavior, and ligand architecture. These features are difficult to resolve using classical surface
and material characterization strategies, and NMR provides a complementary avenue of
characterization. In this review, we examine how solution NMR can be combined with other
analytical techniques to investigate protein behavior on NP surfaces.
1.2

Introduction
Nanoparticles (NP) have been used to advance medicine and biotechnology, with

applications ranging from clinical diagnosis, drug delivery, and biosensing. 1 Nanoparticle
composition can vary significantly from metals to inorganic semiconductors.2 In addition, there
are a variety of surface modifications available depending on the desired physicochemical and
biological activities. Identifying nanoparticle interfaces that facilitate both specific and nonspecific interactions in biological media is a daunting task. 3-4 Nano-bio assemblies require the
use of various analytical approaches to gain fundamental insight on these novel materials.
Furthermore, when NPs are introduced into biological media composed of nucleic acids, lipids,
and proteins will spontaneously interact forming a biomolecular corona.5 Due to these
phenomena, and given the broad medical applications of NPs, understanding NP-protein
interactions is of paramount importance. It is hypothesized that transfer of a protein from
2

aqueous medium to the NP corona can affect protein’s conformation and motions, which in turn
can interfere with the NPs surface properties. Nanoparticle curvature is prone to induce
conformational changes in both the secondary and tertiary structures of many proteins.6-8 For
example, Satzer et al. used circular dichroism (CD) spectroscopy to determine that α-helical
content for both myoglobin and bovine serum albumin (BSA) decreased significantly in the
presence of 150 nm gold nanoparticles (AuNPs).9
Different analytical tools have been employed to characterize biocorona formation on NP
surfaces. These techniques include surface plasmon resonance (SPR),10-13 transmission electron
microscopy (TEM),5,14-17 mass spectrometry (MS) based proteomics,18-20 chromatography,21
fluorescence spectroscopy,22-26 CD spectroscopy,6,26-28 electrophoresis (gel, capillary, and 2D
electrophoresis),13,29-30 dynamic light scattering (DLS),16,23,31-32 isothermal titration calorimetry
(ITC),33-36 infrared spectroscopy (FTIR),37-38 and nuclear magnetic resonance spectroscopy
(NMR).39-43 These techniques have been used to identify the structural and conformational
changes of various proteins onto the NP surface.
Solution NMR spectroscopy has proven to be an outstanding tool to understand
conformation, orientation, and dynamics of the molecules involved in biocorona formation on
various NP surfaces, including AuNPs and silica nanoparticles (SiNPs). Also, solid-state NMR
has been used for structural determination of peptides on hydroxyapatite surfaces.44 However,
solid-state NMR studies of the NP biocorona are less frequently found in the literature.
Solution NMR spectroscopy is unique among analytical techniques, because of its ability
to probe local motions in the time frame of picoseconds to hours.45 Effects of intermolecular
interactions can be measured with high precision and mapped onto protein structures to
3

understand the interaction sites of the protein.46 Additional solution NMR experiments can be
used to extract information about the protein, including steady-state kinetics, structural
thermodynamics, and diffusion constants. Solution NMR techniques are generally limited by the
sample’s molecular size (<35 kDa), though relaxation optimized NMR methods have opened the
door to complexes reaching 1 MDa.47 Nevertheless, acquiring information on NP-protein
interactions using NMR is extremely challenging. In the past few years, NMR studies have
contributed to new insights in the structure and function of biomolecule-NP conjugates. This
review aims to summarize recent work on NP bioconjugates and explain how NMR can be used
to understand the fundamentals of NP-protein interactions.
1.3

Non-NMR Approaches for Nanoparticle Studies
Under physiological conditions, biological molecules spontaneously adsorb onto NP

surfaces.48 This in turn changes the surface properties of the NP by the formation of a
biocorona.49 Understanding the biophysical characteristics of the NP biocorona can lead to new
applications in the biological and medical fields. The biocorona consists of proteins,
carbohydrates, lipids, and nucleic acids that either loosely (soft corona) or tightly (hard corona)
associate with the NP surface. Measurement of binding affinities, binding capacities, association
and dissociation rates, and stoichiometries of these biomolecules are needed for a complete
understanding of the corona’s properties. Different analytical techniques have been employed to
study NP-protein interactions, specifically UV-Vis, MS, DLS, ITC, and CD. Each technique has
unique advantages and disadvantages when investigating NP-protein interactions.

4

1.3.1

Spectroscopic Approaches for Characterizing Binding (UV-Vis, Fluorescence,
Raman, and CD)
In UV-Visible (UV-Vis) spectroscopy, the localized surface plasmon resonance (LSPR)

phenomenon is used to characterize the metallic NPs, such as AuNP and silver nanoparticles
(AgNPs), and its conjugates.26,42,50-54 LSPR is only present in plasmonic NPs and cannot be used
in non-metallic systems, such as liposomes and SiNPs. The LSPR peak shape and size is caused
by a collective oscillation of free electrons of the metallic particle. A shift and broadening of the
absorption spectra for the NP-protein complex will depend on the bioconjugate size, aggregation
state, and the local dielectric environment.52,55 Due to this phenomenon, UV-Vis is widely used
to quantify metallic NPs and qualitatively measure conjugate binding. In a previous study, αsynuclein was titrated with various concentrations of AuNPs, and the plasmon peak shift (Δλ)
versus α-synuclein concentration was graphed.56 A Langmuir isotherm model was fit to the data
to extract the equilibrium association constant (Ka = 7.9 ± 1.1×106). UV-Vis is a noninvasive
method, where the integrity of the sample is not compromised, and is an inexpensive technique
that requires little sample preparation. The major disadvantage of UV-Vis is the adsorption
spectrum is highly influenced by solvent, pH, temperature, and high electrolyte concentration.
Moreover, very little can be learned about biomolecular structure using UV-Vis spectroscopy
alone.
Fluorescence, Raman, and CD spectroscopy can be effectively used to detect NP-protein
binding.26,55,57-64 These techniques’ advantage is that they do not require plasmonic NP systems.
However, several factors can complicate each of these methods. For example, fluorescence
spectroscopy typically requires natural fluorophores, such as tyrosine or tryptophan in
proteins.24,26,55,57-59,62-69 If these are not present, cysteine or amines can be labeled with
5

fluorescent probes, such as fluorescein, to study their structural and dynamic properties. 70
Fluorescence correlation spectroscopy (FCS), a technique that measures the fluorescence bursts
emitted by particles diffusing through small volumes, has been used to quantitatively study
human serum albumin (HSA) adsorbed to polymer coated FePt and CdSe/ZnS nanoparticles.
Autocorrelation analysis of fluorescence emission yields a characteristic diffusion time scale (𝜏𝐷 )
corresponding to the hydrodynamic radius 𝑅𝐻 of the NP bioconjugates.23 Even though
fluorescence based approaches are highly sensitive , the main disadvantage is the addition of
fluorescent probes that can alter the NP-protein interaction. Also, the inner filter effect (IFE) and
light scattering from the proteins or NPs may complicate the interpretation of fluorescence
experiments.71-74
Some of the drawbacks of fluorescence spectroscopy are avoided by Raman
spectroscopy, a non-destructive, label-free, highly specific technique that has a distinct
fingerprint for solid and liquid solutions.75-76 Raman spectroscopy measures the NP bioconjugate
in aqueous solutions with great spectral resolution. Surface enhanced Raman spectroscopy
(SERS) has improved the measurements of Raman spectroscopy with higher sensitivity and
higher selectivity of chemical groups. SERS has been used to determine the structural and
conformational changes of protein on metal NP surfaces. 76-80 For example, Szekeres et al. used
SERS to identify structural changes in BSA molecules when attached to AuNPs, finding that
BSA undergo structural changes which depends on the BSA concentration. 78 Apart from protein
conformation data, the morphological changes in AuNP when interacting with protein are also
detected through SERS spectra. One drawback is the intense laser heating the NP-protein
conjugate, which can alter the structure and conformation, giving rise to misleading results.
6

Though neither fluorescence nor Raman spectroscopy can detect secondary or tertiary
structure changes in proteins, CD is used extensively to determine the secondary structure of
proteins and how these structures change upon binding to NP surfaces.28,81 To exhibit a CD
signal, a molecule must be chiral; however, NP surfaces are not typically chiral and will not
generally interfere with signal and interpretation of data. In a previous study done by Deng et al.,
poly (acrylic acid)-coated gold nanoparticles (PAA–AuNP) were titrated with fibrinogen, a large
protein that consists of both α-helices and β-sheets, and far-ultraviolet circular dichroism (UVCD) was used to monitor protein structural changes upon NP interaction. 28 Indeed, fibrinogen
secondary structure was lost with the addition of PAA-AuNP indicated by the progressive
increase in ellipticity. They concluded that PAA-AuNP induced structural changes and exposed
its C-terminus.28 As a drawback, UV-CD provides only a rough estimation of conformational
changes, since the unbound (native) protein is typically left in the cuvette when the NP-bound
protein is measured, and the unbound protein often dominates the observed signal. Separating
NP-bound protein by centrifugation, or performing a difference measurement are viable
alternatives, but the signal originating solely from NP-bound proteins is often very weak.37,54,64,82
1.3.2

Non-Spectroscopic Approaches for Characterizing Binding (Light Scattering,
Chromatography, Mass Spectrometry, and Calorimetry)
Other, non-spectroscopic approaches are also useful, and include dynamic light

scattering, chromatography, mass spectrometry, and isothermal titration calorimetry. Dynamic
light scattering (DLS) is a widely used technique to determine the hydrodynamic size of NPs in
suspension.16,83-84 DLS measures the scattering intensity fluctuations caused by the Brownian
motion of NPs in solution and uses the Stokes-Einstein equation to relate the diffusion
coefficient to the NP size. The measured hydrodynamic diameter reflects the dimensions of the
7

NP as well as the corona layer bound to the NP surface in solution.16 The hydrodynamic radius
measured by DLS can also be used to determine the binding ratio of protein to NP. Woods et al.
studied the monolayer formation of BCA and GB3 (the third binding domain of protein G) on
AuNP using DLS.85 The size increment when both proteins adsorbed to AuNP was similar to the
values observed by TEM and the values predicted by the native protein structure.85 DLS is a
nonperturbative, fast, and accurate method, but the disadvantage is the need of a dust free and
dilute sample that has a monodisperse population. Also, this method suffers from low sensitivity
toward small particles and possible interference from light-absorbing species.
Light scattering can be extended in several ways, and two approaches in particular have
been applied to nanoparticle-biomolecular interactions. Many DLS systems are capable of
measuring electrophoretic light scattering, from which zeta potential can be determined. 80,86-87
Nanoparticles in solution have an electrostatic charge on their surface, and the zeta potential
measures this potential of the electric double layer relative to the bulk solution. It is therefore
related to surface charge, and particles with larger zeta potentials tend to form more stable
suspensions.88. Biomolecules in solution can adsorb onto the NP surface, changing the surface
potential and nanoparticle stability. Dobrovolskaia et al. examined how of NP size affected
longevity in the bloodstream upon binding to plasma.16 AuNPs of size 30 and 50 nm were
incubated with plasma, which increased the zeta potential from -38.2 mV to -16.4 mV. A similar
change in zeta potential was observed for 50 nm AuNP, and both changes corresponded to an
increase in hydrodynamic radii as blood proteins were adsorbed. An alternative application to
light scattering involves the coupling of static, multiangle light scattering (MALS) with
chromatography. MALS differs from DLS in that scattering intensity is measured at several
8

discrete angles. In ideal cases, both 𝑀𝑟 (the relative molar mass) and the radius of gyration of
nanoparticle can be determined,89 and changes can be monitored in the presence and absence of
biomolecules.90 Overall, applications of light scattering have led to powerful tools for
characterizing NPs, although relating MALS, DLS, and zeta potential protein tertiary structure
on a NP surface can be very challenging.
Chromatographic methods, such as size exclusion chromatography (SEC) or gel filtration
chromatography, are frequently used to separate complex mixtures of biological compounds
based on their size. Gel filtration chromatography has been used to detect protein bound to NPs
and determine the exchange rate by comparing the bound versus free protein elution profiles. 33,9192

Cedervall, et al. introduced a gel filtration-based method to both identify proteins attached to

NPs and the exchange rate of plasma proteins.93 Separation is based on the fact that NPs are too
big to enter the pores of gel filtration media and will appear in the void volume. However, the
free proteins are small enough to enter the pores and separate according to their molecular
weight. One disadvantage is that, if the NP-protein interactions are weak, the large dilutions can
disturb the NP-protein equilibrium. There are also inherent drawbacks due to the sensitivity of
the SEC, including lower precision, accuracy, and longer experiment times. Another potential
pitfall is the interaction of NPs with the stationary phase of the column.94 In this case, an
alternative approach, asymmetrical flow field-flow fractionation (AF4), can be employed. AF4
has no stationary phase, and a semipermeable membrane is used instead. During fractionation, a
cross-flow is applied through the membrane, creating a concentration gradient that separates
molecules based on their molecular size. Adsorption to the membrane can be problematic, but
AF4 is thought to be more gentle than SEC,95 and several excellent reviews discuss the strengths
9

and weaknesses of AF4 applied to NPs.95-97 Like SEC, AF4 can be used to separate complex
mixtures of proteins and NPs before downstream analysis. When coupled with DLS or MALS,
SEC and AF4 can be an extremely powerful tool for characterizing dispersions of polydisperse
NP solutions.
Electrophoresis is another useful technique to separate complex NP-protein mixtures that
provides qualitative and quantitative analysis. Polyacrylamide gel electrophoresis (PAGE) is one
of the most widely used methods to separate NP-protein complexes.3,58,93,98-100 Macromolecules
are differentiated according to their electrophoretic mobility, which is a function of the
molecule’s length, conformation and charge. For proteins, sodium dodecyl sulfate (SDS) is used
to denature proteins and give them a uniform charge/size ratio. García et al. used SDS-PAGE gel
electrophoresis to identify the adsorbed proteins onto several different classes of AuNPs after
incubation with fetal bovine serum.101 The data suggested that cationic and anionic AuNPs
adsorbed a larger amount of proteins compared to AuNPs coated with polyethylene glycol (PEG)
and glycans. Even though SDS-PAGE is an effective tool to identify the composition of the
protein corona, it suffers from poor protein separation if the protein mixture is too complex
resulting in comigration of several proteins with similar size.
Mass spectrometry (MS) is a high throughput, sensitive analytical technique used to
monitor larger proteins (up to ~100 kDa) interacting with NPs. The two main ionization methods
used to investigate biomolecules are matrix-assisted laser desorption ionization (MALDI) and
electrospray ionization (ESI). Protein samples are often digested using proteolytic enzymes into
smaller fragments that are more suitable for the mass range of instruments. MS can provide both
qualitative and quantitative information regarding the protein mixtures present on NP surfaces,
10

and MS can be used in parallel with chromatographic and gel-based methods to identify the
composition of the protein corona.3,65,93,100,102-104 Importantly, the use of protein fragments
enables one to investigate structural questions on the NP surface. For example, Shrivastava et al.
identified that cytochrome c had a specific orientation on SiNPs using post translational
modification and MS. Cytochrome c lysine residues were acetylated in solution after complete
protein saturation of the SiNP surface. Then, a pepsin digest was used to identify and compare
the intensity ratios from MALDI-TOF (time of flight) for acetylated cytochrome c free and
bound states in solution. Results showed that the lysine residues bound to SiNP surface had a
lower intensity, resulting from the steric occlusion of lysine residues during acetylation when
bound to SiNPs. Even though MS is a destructive method, it provides qualitative and quantitative
values that reflect the protein abundance in the protein corona, and it often requires
comparatively much smaller amounts of sample.
Isothermal titration calorimetry (ITC) can be used to directly measure the enthalpy
change when proteins interact with NPs.33,35-36,64 In general, to measure the enthalpy change, the
protein of interest is gradually added to a solution containing NPs and the evolved heat of
binding is measured. These heats are calculated using the power required to maintain isothermal
conditions. Fitting a thermodynamic model to the heats produces parameters like stoichiometry
and the enthalpy of binding. For example, Cedervall et al. added HSA into copolymer
nanoparticles to measure the stoichiometry, affinity, and enthalpy of the NP-protein interaction.93
The equilibrium association constant was calculated to be 2x106 for the interaction between HSA
and the NP surface.33 They effectively used ITC to demonstrate the thermodynamic nature
between NP-protein complex formation and protein conformational changes upon binding.
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Several drawbacks exist when using ITC to study protein-NP binding. For one, the method
requires high sample concentrations (0.1-1 mM) and volumes (~1 mL). An additional challenge
is that adsorption may not produce a measurable heat, even when NPs are quite concentrated.
Finally, if multiple steps occur, e.g. binding and unfolding, ITC thermograms may be
challenging to interpret. Despite these challenges, ITC remains a useful tool for understanding
the strength of biomolecule-NP interactions.
In summary, each of the analytical methods mentioned above has their own advantages
and disadvantages that coincides with the physical properties being measured. In the next
section, we discuss how NMR spectroscopy can complement the techniques described above.
NMR has many unique advantages, as it is non-destructive and uses relevant aqueous solvents
for biological samples. NMR techniques can be used to monitor fine structural changes, owing to
its ability to probe individual residues. This information is particularly useful when a molecule is
interacting with a ligand or NP. Finally, NMR can be applied to a wide variety of samples in the
solution and the solid-state, providing both direct and indirect measurements of molecular
dynamics.
1.4

Solid-State NMR Approaches for Nanoparticle Studies
While the focus of the current review is solution NMR, solid-state NMR is an emerging

analytical tool for understanding protein behavior on NP surfaces. Despite this, it has been
infrequently used thus far to study NP-protein interactions.41 High-resolution solid-state NMR
techniques, both newly developed and traditional, can provide structural and motional details at
the atomic and molecular level. The interfacial interactions revealed by NMR are
straightforward, and interpretations are separated into chemical and physical principles that
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underlie the binding of the molecules to the surface. Solid-state NMR can be used to extract data
from biomolecules directly interacting with mesogenic and amorphous solids, where
conventional methods, like X-ray crystallography and solution NMR, fail. One drawback using
solid-state NMR is its inherently low sensitivity (though dynamic nuclear polarization methods
to boost signal are rapidly advancing),105 and its requirement that surface adsorption should be
relatively long-lived. Long et al. studied the structural and dynamic characterization of salivary
statherin adsorbed to hydroxyapatite surface using solid-state NMR. This data suggested the
interaction of statherin was mediated by the N-terminus, where two negatively charged
phosphoserines and three carboxylate-containing side chains were located.44 In a similar study,
ultrafast magic-angle-spinning (MAS) 1H NMR and multinuclear and multidimensional (13C and
15

N) NMR were used to determine the structure of the large protein assembly conjugated to

PEGylated AuNP.106 They focused on the E. coli asparaginase II (ANSII) protein, which was
covalently tethered to AuNPs. Two-dimensional 1H-15N CP-HSQC (cross-polarization
heteronuclear single-quantum coherence) solid state NMR spectra were collected for both free
ANSII and bound to PEGylated AuNPs. The spectra were superimposable indicating the
retention of native structure on the AuNP surface. Chemical shift perturbation analysis of the 2D
1

H-15N CP-HSQC spectrum of ANSII-AuNPs revealed that the largest variations involved the

residues located on the protein surface or on the loops. Even though the covalent tether was in a
sense artificial, these data suggest heteronuclear solid-state NMR spectra can be effectively used
to understand the structural and dynamics of biomolecules on NPs.
In another study, Bower et al. employed solid state NMR to obtain the structure of
surface-immobilized peptide (LKα14) onto AuNPs.107 These peptides covalently bind to
13

alkanethiolates and self-assemble as monolayers on the colloidal AuNPs. Ramachandran angles
(φ and ψ) for the immobilized peptides were determined by measuring the distances between
backbone carbonyl 13C spins. A double quantum filtered dipolar coupling with a windowless
sequence (DQDRAWS) experiment was used, and additional information was obtained by
determining the relative orientation of chemical shift anisotropy tensors of 13C carbonyl spins on
adjacent peptide planes. Solid state NMR structural measurements indicated a slight
conformational change in the backbone torsion angles when the peptide adsorbed onto the NP
surface. This change might be a consequence of the peptides adsorbing on an immobile, twodimensional surface rather than interacting with other flexible peptides to reach an energy
minimum. They concluded that the LKα14 peptide adopts helical structure on the NP, because
this conformation exposes the maximum number of lysine residues for attachment. While not
widely used in NP-protein interaction studies, solid state NMR has great potential to reveal the
structural details of surface adsorbed proteins, and advances like dynamic nuclear polarization 108
may accelerate the development of solid state NMR in this area.
1.5

Solution NMR Approaches for Nanoparticle Studies
Solution NMR spectroscopy exploits the non-zero spin properties of nuclei, mainly 1H,

13

C, and 15N, to determine the chemical shifts, relative intensities, and linewidths for NMR-

visible spin systems. These parameters depend on the dynamics and conformation of the free and
bound macromolecule (often proteins). The local chemical environment for each nucleus results
in a unique chemical shift, whereas the signal intensity depends on the number of nuclei
resonating at that chemical shift. Finally, linewidth is related to how quickly the nuclei relax
(R2, s-1). R2 is influenced by many factors, including protein rotational correlation time (τc), local
14

motion, and chemical (e.g. conformational, binding) exchange. When nanoparticles are added to
a solution containing protein, the protein signals are expected to be perturbed depending on the
nature of the NP-protein interaction. The most significant effect happens when rotational
diffusion is slowed. This occurs when large NP-protein assemblies are formed, resulting in
decreased signal intensity and significant line broadening (Figure 1.1).
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Figure 1.1

Comparison of exchange between a protein binding to a similarly-sized molecular
target traditional protein-protein binding and nanoparticle-protein binding.

For a monomer (P) to dimer (2P) exchange (yellow background, left panels), individual NMR
signals are observed for both species in the slow exchange regime (bottom), and a weighted
average signal is observed for fast-exchanging species (top). Intermediate exchange broadens the
signal. Nanoparticle binding differs because of extremely slow rotational correlation time (𝜏𝑐 ) in
the bound state (blue background, center and right panels). For example, protein 𝜏𝑐 values
typically range from 2-20 ns, whereas an 80 nm (diameter) NP has a 𝜏𝑐 of approximately 105 ns,
and 𝜏𝑐 for a 10 nm NP is 100 ns. In the slow exchange limit, binding to a NP decreases the signal
intensity as before, but no signals are observed from the nanoparticle-bound species because of
its slow rotational correlation time (bottom middle and bottom left panels). As the
conformational exchange rate increases, the nanoparticle-bound state continues to broaden the
free protein signals, complicating detection. With 10% of protein bound, the signal becomes
undetectably broad in the fast exchange limit (top middle). Even with only 1% of bound protein,
the effect on the free protein signal is substantial (top right). Spectra are simulated for 15N
resonances at 800 MHz using 20 nm NPs in water for 𝑘𝑒𝑥 = 2.5 s-1 (slow), 𝑘𝑒𝑥 = 2.5 × 103 s-1
(intermediate) and 𝑘𝑒𝑥 = 2.5 × 106 s-1 (fast).
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In the context of nanoparticle binding, chemical exchange occurs when association with
the nanoparticle causes a modulation in a nuclei’s chemical environment. The change in
environment will generally induce both a change in chemical shift (|Δ𝜈|) and a change in
relaxation, because proteins may alter their conformation and because nanoparticle τ c values are
significantly greater than those for soluble proteins. A two-state model is often used to describe
binding, and for fixed NP and protein concentrations, the on and off rates are each associated
𝑎𝑝𝑝

with a rate constant, 𝑘𝑜𝑛 and 𝑘𝑜𝑓𝑓 . Because the concentration of NP binding sites is often
𝑎𝑝𝑝

𝑎𝑝𝑝

ambiguous, the exchange rate 𝑘𝑒𝑥 is defined as 𝑘𝑜𝑛 + 𝑘𝑜𝑓𝑓 , where 𝑘𝑜𝑛 is an apparent first
order rate constant. Traditionally, chemical exchange is classified into three categories: slow
(𝑘𝑒𝑥 ≪ |Δ𝜈|), intermediate (𝑘𝑒𝑥 ≈ |Δ𝜈|), and fast (𝑘𝑒𝑥 ≫ |Δ𝜈|). In NP systems, and additional
contribution – lifetime line broadening – is also present, distinct from the line broadening caused
by chemical exchange on the intermediate chemical shift time scale. 109 This lifetime line
broadening occurs because the NP relaxation rate is extremely fast, owing to the size of the NP
and its slower rotational correlation time (the 𝜏𝑐 of a NP can be hundreds of ns or more, whereas
protein 𝜏𝑐 values typically range from 2-20 ns). Lifetime line broadening is different from
intermediate chemical shift timescale exchange broadening because it can occur even when there
is no chemical shift change (Δ𝜈 = 0). Under these conditions, the exchange regime is determined
by the difference in relaxation rates, Δ𝑅20 = 𝑅2𝑁𝑃 − 𝑅2𝑃 , where 𝑅2𝑁𝑃 and 𝑅2𝑃 are the 𝑅2 rates of the
NP-protein complex and the free protein, respectively. Then, slow exchange is 𝑘𝑒𝑥 ≪ Δ𝑅20 ,
intermediate exchange is 𝑘𝑒𝑥 ≈ Δ𝑅20 , and fast exchange is 𝑘𝑒𝑥 ≫ Δ𝑅20 .109 Under slow exchange
(typically s–ms), separate signals are observed for the two states, but the apparent 𝑅2 of the
𝑎𝑝𝑝

small, easily visible state will be the sum of intrinsic 𝑅2 of that state plus 𝑘𝑜𝑛 As the rate
17

increases, the bound and free signals gradually broaden and coalesce under intermediate
exchange. Eventually, the average signal sharpens as exchange becomes fast. The exchange
contribution – either from chemical exchange or lifetime line broadening – can be quantified in
part by measuring the difference in relaxation rate in the presence and absence of nanoparticles,
where the observed relaxation rate with NPs present is 𝑅2𝑜𝑏𝑠 and Δ𝑅2𝑜𝑏𝑠 is defined as Δ𝑅2𝑜𝑏𝑠 =
𝑅2𝑜𝑏𝑠 − 𝑅2𝑃 . The observed difference in relaxation rates (Δ𝑅2𝑜𝑏𝑠 ) will have different functional
forms depending on whether exchange is fast, intermediate, or slow. This behavior has been
discussed extensively for binding of two protein-sized macromolecules.109-110
Figure 1.1 (left column) demonstrates exchange graphically for the dimerization of two
similarly-sized protein species. Under slow exchange, when the dimeric form is populated at
10% total protein, a small but visible signal is observed corresponding to the dimer (bottom
panel). This species will have a somewhat broader linewidth, resulting from the increased size of
the dimeric species. The peak corresponding to the monomer will be quantitatively reduced in
proportion to the amount of dimeric species. Moreover, the integral of each peak will be strictly
proportional to the number of molecules (nuclear spins) in the monomeric and dimeric states.
Intermediate and fast exchange (upper two panels) have similar features for a 10% dimer
population: only a single peak is observed. However, in intermediate exchange (middle left
panel), the monomeric peak broadens significantly because of the dimer-monomer exchange,
even though the dimer represents a small fraction of the ensemble. In fast exchange, the average
peak sharpens and has shifted according to the population weighted chemical shift (top left
panel).
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The picture described above changes significantly when one of the binding partners is a
nanoparticle. The central column in Figure 1.1 demonstrates the behavior when a protein binds to
a 20 nm nanoparticle (10% protein bound). Under slow exchange, the bound species peak is not
observed at all due to the extremely slow rotational diffusion of the nanoparticle. Using a noninteracting reference, one can still quantify the amount of bound protein by measuring the
diminished peak intensity (bottom center panel).111 However, direct observation of the
nanoparticle-associated species is impossible because of the nanoparticle’s large size. As the
exchange rate increases from slow to fast, the free protein peak becomes significantly broader,
eventually becoming impossible to observe (top center panel). Because of the large difference in
R2 values between the bound and free states, very little nanoparticle binding is needed in the fast
exchange regime to elicit a significant effect. The rightmost column in Figure 1.1 shows the
effect when only 1% of protein is in the nanoparticle-associated state. While the change is
imperceptible under slow exchange, the large nanoparticle R2 causes significant broadening
under fast exchange, far more than would be expected for a protein binding to a similarly sized
molecular target.
Different nanoparticle surfaces exhibit different exchange behaviors. In our experience,
citrate-coated spherical AuNPs always exhibit extremely slow exchange, with no line broadening
observed.112 On the other hand, other nanoparticle chemistries, like SiNP exhibit faster exchange,
leading to a marked increase in the observed protein R2 values.113-115 Either way, the surfaceassociated protein is not directly detectable, because it experiences roughly the same 𝜏𝑐 (i.e.
extremely slowly tumbling) as the bare nanoparticle. In the remainder of this review, we will
discuss how solution NMR spectroscopy can be used to probe the nanoparticle-associated state
19

indirectly. In general, one of two strategies are used to accomplish this. For slowly exchanging
nanoparticle surfaces, protein concentrations are chosen so that a significant fraction of the total
protein concentration is associated with the nanoparticle (Figure 1.1, bottom center panel).
Provided that Δ𝑅2𝑜𝑏𝑠 ≈ 0, bound protein can be quantified using the reduction in the nonassociated signal, and the protein can be displaced using small molecules (e.g.
mercaptobenzimidizole for AuNPs).111 For rapidly exchanging nanoparticle surfaces, conditions
are chosen so that only a small fraction of the total protein concentration interacts with the
nanoparticle. Then, relaxation behavior and other properties are used to study the bound
state,43,116-119 offering the possibility of performing numerous experiments that can address a
variety of features in studying NP-protein interactions.
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Figure 1.2

The CPMG and DEST profiles for 15N GB3, residue E24.

GB3 CPMG profiles binding with (A) AuNP surface and (B) SiNP surface. No relaxation
dispersion is observed for GB3 on either AuNPs or SiNPs, as evidenced by the flat response of
𝑅2 versus CPMG frequency. (C) 500 μM GB3 DEST profile binding with 0.25 μM SiNPs. Two
saturation fields are used, 500 Hz (red points) and 350 Hz (blue points). These saturation fields
selectively saturate the resonances of the NP-bound protein, resulting in a decrease in the
intensity of observable resonances of the protein free in solution. This decrease occurs because
the nanoparticle-bound spins are in chemical exchange with the observable spins in solution. The
saturation behavior can be fit (red and blue lines) to a continuous function to determine the
𝑎𝑝𝑝
kinetic rate constants for association and dissociation. In this case for protein association, 𝑘𝑜𝑛 is
4 s-1 and 𝑘𝑜𝑓𝑓 is 19.8 s-1.
As an example, we have measured 15N 𝑅2 values for the small GB3 protein using 15 nm,
citrate-coated AuNPs and 30 nm spherical SiNPs (Figure 1.2). For this small, globular protein,
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all residues exhibit similar behavior. 15N CPMG experiments for residue 24 reveal a nearly flat
response with no apparent relaxation dispersion for either AuNPs or SiNPs. For GB3, which is in
slow exchange with the AuNP-bound state, no dispersion is observed (Δ𝑅2𝑜𝑏𝑠 ≈ 0) because only
the free state is visible, and there is effectively no exchange on the timescale of the NMR
experiment.112 This is confirmed by the behavior of GB3 in the absence and presence of AuNPs:
the slow exchange behavior results in nearly identical R2 values in the presence and absence of
AuNPs (Figure 1.2A). For SiNPs, different behavior is observed (Figure 1.2B). While the
relaxation dispersion profile is still flat, the difference in 𝑅2 values with and without NPs is
significant (Δ𝑅2𝑜𝑏𝑠 ≠ 0), even when the nanoparticle concentration is extremely small relative to
the protein concentration (500 μM GB3 and 0.25 μM SiNPs). The Δ𝑅2𝑜𝑏𝑠 is large because the
protein experiences exchange, and therefore the observed 𝑅2𝑜𝑏𝑠 value is influenced by lifetime
line broadening (compare to Figure 1.1, top right panel).110 For GB3 on SiNPs, the relaxation
dispersion profile is flat as the large nanoparticle R2 precludes refocusing at any of the applied
CPMG frequencies. This is in stark contrast to GB3 on AuNPs, where the profile is flat because
exchange is very slow.
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1.5.1

1D Proton NMR, Quantitative NMR, and Half-Filter Experiments

Figure 1.3

1D and 2D spectra of two proteins competing for AuNP surface

(A) The use of 1D half filter experiment to quantify binding of two proteins in same solution
with AuNPs. GB3 (13C labeled) and ubiquitin (Ubq, 15N labeled) are in the same solution, and 80
nM AuNPs are added. The 15N and 13C filter can be applied to differentiate proton signals
originating from each protein independently, and quantitative NMR approaches can be used to
measure binding. The residual water signal has been removed for clarity. (B) Backbone amide
1
H-15N heteronuclear single-quantum coherence (HSQC) experiment to quantify two proteins
isotopically labeled the same in the nanoparticle solution. 15N labeled GB3 and 15N labeled Ubq
are mixed in the same solution with 80 nM AuNP. The peak intensity perturbation measured for
25 μM GB3 and 25 μM Ubq in the presence of AuNP (I, red spectra) compared to the absence of
AuNP (Io, blue spectra). (C) The 1H-15N HSQC experiment can be used to determine the binding
capacity for each protein by plotting the bound concentration versus various AuNP
concentrations. The HSQC spectral intensities are used to determine the bound concentration
relative to an external standard. Here, 20 μM GB3 is mixed with 0, 20, 40, 60, and 80 nM AuNP
to identify how much is bound to the NP surface. Observed concentrations for GB3 (blue circles)
are plotted against the expected values for a folded monolayer of protein on the NP surface
(black circles and solid line).
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In 1D proton (1H) NMR, the protein amide and aliphatic regions are clearly
distinguishable. This signal can be used to quantify the bound protein concentration to NP when
the interaction is in slow regime, where line broadening is not observed in the presence of NPs.
Protein (typically at concentrations of 20-50 μM) is titrated with various concentrations of NPs
to identify how the protein interacts with NP using 1D NMR. The 1D 1H signal intensity
decreases as the NP concentration increases. The signal loss can be directly related to the bound
protein concentration,111 which increases as the NP concentration increases. When the bound
protein concentration is plotted against the total NP concentration, one can estimate the binding
capacity of the NP, provided that binding is sufficiently tight (Kd < 1 μM).111,120 Binding
capacity reflects the total number of proteins bound to the nanoparticle, regardless of whether the
proteins form a single layer or multiple layers on the NP surface, and regardless of whether the
protein unfolds on the surface. This is true because, in the slow exchange regime (Figure 1.1,
bottom panels), the free peak simply represents the protein fraction not associated with the NP.
Normally, nothing can be understood about directly the surface-bound protein; however, using
this novel, yet simple method, we found a good agreement between the binding capacity
measured by NMR and the binding capacity predicted assuming a folded monolayer for six
different proteins on a 15 nm AuNP.111
1D half-filter experiment121 (Figure 1.3A) can be used to extend 1D 1H quantitation to
monitor the competitive binding of multiple proteins to a NP surface. NMR spectra are obtained,
and the half-filter NMR experiment is used for signal filtering of 15N and 13C attached protons.
This experiment requires that proteins be isotopically enriched with either 13C or 15N, but not
both. For each data point, three spectra are recorded: one with no filter (used for comparison with
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a reference standard, either external or internal), one with a 13C filter (used to select 13C-attached
protons), and one with a 15N filter (used to select 15N-attached protons). Relative concentrations
are calculated with respect to the standard, which can be compared to a sample with no NPs in
order to obtain absolute concentrations. This method was used to measure the competition
between the wild-type (WT) GB3 protein and all of its lysine to alanine variants, allowing an
investigation of which lysine residues matter most in NP binding.39 The advantage of the 1D
half-filter experiments is its ability to detect two protein-NP mixtures in situ in the same sample.
However, its limitation is that it requires distinct isotopic labeling with good peak dispersion,
making it challenging to investigate complex mixtures of three or more proteins.
1.5.2

Two-Dimensional NMR Methods
The heteronuclear single-quantum coherence spectrum (1H-15N HSQC) of a protein can

be regarded as the fingerprint for the protein backbone. 122 By monitoring 2D NMR spectra, one
can identify perturbations in backbone amide nitrogen and proton chemical shifts, linewidths, or
intensities upon binding to a NP. These perturbations are subject to the effects shown in Figure
1.1, and a range of behaviors can be observed depending on the timescale of exchange and the
size of the NPs. To date, 2D NMR has been used to identify and map residues involved in
binding to NP, as well as identify the orientation and conformational changes of proteins upon
binding (vide infra). HSQC is widely used to study proteins up to 35 kDa, 123 and transverse
relaxation optimized spectroscopy (TROSY)124 can be used to extend this size limitation up to
70-80 kDa or even larger.125 However, even with protein perdeuteration methods,126 backbone
and methyl TROSY methods are not currently able to overcome the relaxation challenges
encountered by proteins on NP surfaces. In addition, care must be taken to ensure that any
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chemical shift perturbations observed are actually caused by NP adsorption and not buffer
mismatch between the protein and NP solutions. This is particularly important when using
commercially prepared NPs, where the NP storage buffer might not be precisely known.
As with 1D experiments, quantitative HSQC spectra can be used to measure the binding
capacity of NPs provided the system is in slow exchange and the line shape is unaffected. The
relative signal intensity will decrease upon addition of NPs, corresponding to protein binding to
the NP surface. As before, the binding capacity can be determined by identifying the bound
concentration when protein interacts with NPs in solution (Figure 1.3C). Using two dimensional
methods also has the advantage of simplifying competition experiments, provided that
resonances in the two-dimensional plane do not overlap. For example, Figure 1.3B shows GB3
and Ubq 15N HSQC resonances when mixed with AuNPs, an analogous situation to what is
shown as a one-dimensional spectrum in Figure 1.3A. When exchange is fast enough so that line
broadening does not dominate, it is possible that traditional chemical shift perturbation
experiments can be observed.127 The requirement of fast exchange limits this application of
HSQC spectra to the soft corona, or to NPs where the surface chemistry prevents long-lived
biomolecular binding. This is because proteins and nucleic acids must be weakly associated and
in rapid exchange for chemical shift perturbations to be observed as they would in a traditional
protein-protein interaction study.
1.5.3

Hydrogen-Deuterium Exchange (HDX)
NMR-based HDX experiments monitor the amide protons as they exchange with

deuterated solvent. This exchange is extremely sensitive to structural changes and other
environmental factors, such as pH, temperature, and primary sequence. 128-129 By monitoring
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deuteration state, HDX has the potential to alleviate the relaxation challenges depicted in Figure
1.1. This is because, while transverse nuclear magnetization relaxes rapidly on the surface of a
NP, chemical substitution of H to D is a structural probe that will persist throughout adsorption
and desorption from the surface. HDX measurements can be measured in several ways in the
context of biomolecule-NP interactions. For example, real-time NMR HDX experiments monitor
the exchange of H to D directly after the buffer solution is rapidly exchanged from H2O to
D2O.129 Two-dimensional NMR spectra are recorded continuously, and the spectral signal
gradually decays as protons are exchanged for deuterons, which are not observed in a 1H-15N
HSQC experiment. Acquisition of real-time HDX has been facilitated by rapid-pulse
methodologies like SOFAST130 and BEST,131 which can produce two dimensional spectra in as
little as a few minutes. However, the low sample concentrations used in NP binding
experiments112 can affect sensitivity, making fast acquisition challenging. In systems where
binding to the surface is dynamic (seconds or faster, i.e. the soft corona), perturbations in the
HDX rate are expected if the chemical environment changes significantly during attachment to
the NP surface. Slower timescale binding, such as that observed for the hard corona, may be
more difficult to observe using HDX. This is because there may not be an appreciable exchange
between the bound and unbound states. Real-time HDX measurements are limited to amide
protons exchanging on the timescale of minutes to hours, making this approach practical only for
compact globular proteins, where many protons are buried and protected from exchange by
secondary structures.
An alternative experiment, NH/D SOLEXSY (Solvent Exchange Spectroscopy) can be
used to detect HDX exchange rates occurring at faster time scales (0.2–2 s-1) allowing the
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investigation of HDX in the protein loop regions.132 This experiment is performed in a mixture of
50% H2O-D2O, and HDX occurs continuously throughout the experiment. The peak intensities
acquired through SOLEXSY give rise to a decay curve that can be fit to extract the exchange
rate.132 The measurement of protein HDX using SOLEXSY in the presence of NPs can provide
information on HDX in fast-exchanging loops or exposed amide protons, provided the
nanoparticle interaction is sufficiently fast so that HDX can be observed (i.e., fast-exchanging
soft corona proteins). Prior experiments on AuNPs found that HDX-rates determined using
SOLEXSY differed little between proteins in the presence and absence of NPs. 112 However, this
is likely because AuNP binding forms a hard corona, with little evidence for soft corona
exchange. Consequently, if proteins do not desorb during the SOLEXSY mixing time, no
difference in the HDX rates will be observed even if significant structural change is present
while the protein is on the NP surface.
Faster measurements of HDX using NMR are possible, in particular the WEX-II,133 the
CLEANEX-PM134-135 and the WEX-III TROSY136 experiments. However, as these approaches
measure exchange between the bulk water and the amide backbone, they are strictly speaking
hydrogen exchange experiments, not hydrogen-deuterium exchange experiments. In NP binding,
this is important because each of these approaches uses saturation of water to monitor transfer of
magnetization from the protein to the bulk solvent or vice-versa. Because this saturation rapidly
dephases when the protein is on the NP surface, these experiments are not generally suitable for
studying protein binding to NPs.
HDX rates in the presence of NPs, relative to rates without NPs, can be used to quantify
structural changes that occur on the NP surface. Protection factors are presented as the log value
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of ratio between the exchange rate of protein in solution and protein bound to a NP. It is known
that individual protection factors are related to local protein stability.137-138 HDX studies by
Engel et al. have shown that a beta-lactoglobulin (BLA) protein folding intermediate is oriented
on polystyrene NP in a site-specific manner.139 These researchers determined that unfolding is
initiated by local interactions of protein with polystyrene NPs. The adsorption-initiated partial
unfolding of BLA is faster on NPs (74 s-1) than global protein unfolding. HDX has also been
used to monitor conformational changes of GB3 and Ubq in the presence of 15 nm AuNPs.112
Using real-time HDX, it was found that the presence of AuNPs does not significantly alter
exchange rates for either GB3 or Ubq. This finding strongly suggests that the hard protein corona
on AuNPs does not experience significant desorption, even after hours have passed. In addition,
the fast exchanging soft-corona (if present), does not appear to perturb HDX rates for these two
globular proteins.112 Thus, provided accurate HDX rates can be measured, HDX can be an
extremely useful tool when studying biomolecule-NP binding, both when adsorption is fast as
well as when it is slow.
1.5.4

Saturation Transfer and Relaxation Methods
Larger NP-protein systems tend to have slow rotational diffusion, enhancing the fast

transverse spin relaxation (R2) leading to broadened or even undetectable signals (Figure 1.1).
Reversible binding equilibria can be exploited to study adsorption, allowing the measurement of
kinetic rate constants and other relevant parameters. There are two primary ways for interpreting
relaxation in the context of nanoparticle binding: saturation transfer and quantitative analysis of
the R2 rates. In the dark-state exchange saturation transfer (DEST) experiment, 140-142 longitudinal
15

N magnetization (which decays slowly in slow moving species like NP-bound proteins) of the
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observable species is transferred by chemical exchange from the corresponding invisible state
back to the visible species. This approach was originally applied to characterize oligomers in
amyloid β peptides, and it is generally applicable any time a low molecular weight species is in
exchange with a much larger one.140 The large transverse relaxation rates (𝑅2𝑁𝑃 ) of the
supramolecular entity (i.e. the NP-bound state) preclude direct observation but allow for efficient
partial saturation of the longitudinal magnetization by a weak radio frequency field, even at large
offsets where the signals of the visible species are unaffected. Partial saturation is recorded as an
attenuation of the signals of the visible species. The combination of DEST and two-dimensional
1

H–15N HSQC experiments allows for single-residue resolution of dynamic information on the

NP-bound protein (the NMR-invisible state) to be obtained.141 This information, combined with
measurements of the relaxation rate in the presence and absence of NPs (Δ𝑅2𝑜𝑏𝑠 ), can be used to
𝑎𝑝𝑝

determine the kinetic rate of exchange (𝑘𝑜𝑓𝑓 and 𝑘𝑜𝑛 ; Figure 1.2C).
Exchange processes accessible by DEST generally occur on timescales ranging from ~1
ms to ~1 s, but the specifics will depend on the size of the nanoparticle and the rate of exchange,
as these two parameters directly influence the linewidth in the nanoparticle-associated state. In
addition, under certain circumstances (i.e. when 𝑅2𝑁𝑃 of the NP-bound state is smaller than the
saturation field used), additional relaxation data are needed to resolve the ambiguity in the
population of bound protein (𝑝𝐵 ) and the absolute 𝑅2𝑁𝑃 rate.119 These additional relaxation
𝑚𝑎𝑥 143
measurements (𝐶𝑓𝑎𝑠𝑡
) can be used to determine 𝑝𝐵 , making it straightforward to estimate 𝑅2𝑁𝑃 .

Stated differently, for NPs smaller than 30 nm, DEST and Δ𝑅2𝑜𝑏𝑠 can only determine the product
𝑚𝑎𝑥
of 𝑝𝐵 𝑅2𝑁𝑃 without the collection of 𝐶𝑓𝑎𝑠𝑡
. Thus, in practice, DEST has been applied to liposomal
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NPs and ceria NPs,43,144-145 but it cannot be used for the proteins tested with AuNPs thus far, as
the exchange rate is too slow.112
Measuring relaxation under multiple conditions can also be a useful tool to identify
biomolecular properties on nanoparticle surfaces. This approach takes advantage of the fact that
relaxation is related to rotational diffusion through the spectral density function. The key
parameter in this experiment is Δ𝑅2𝑜𝑏𝑠 , the difference between the relaxation observed in the
presence and absence of NPs, typically when only a low fraction of protein is associated with the
𝑓𝑟𝑒𝑒

NP (Δ𝑅2𝑜𝑏𝑠 = 𝑅2𝑜𝑏𝑠 − 𝑅2

). As a reminder, note that 𝑅2𝑜𝑏𝑠,𝑁𝑃 is not the 𝑅2𝑁𝑃 of the NP-

associated state, which is typically large and precludes direct observation; instead, it is the
apparent relaxation rate in the presence of exchange between the free state and a small
population of the NP-associated state. An extended Lipari-Szabo approach,146 can be used to
separate the spectral density function into contributions from nanoparticle rotational diffusion
and biomolecular rotational diffusion on the NP surface. Assuming that the timescale of NP
binding is separable from the timescale of motion on the NP surface, a model can be fit to the
observed Δ𝑅2 rates in the presence of NPs. This model includes the kinetic on and off rates, an
order parameter for binding, and protein rotation axis angles relative to the NP surface. Ceccon
et al. developed and applied this approach to Ubq on liposomal NPs, where exchange is fast.43
Importantly, two sizes of NPs were needed (103 nm and 27 nm) to unambigiously determine the
model parameters, and it was assumed that Ubq interaction parameters were independent of
nanoparticle size.
An alternative approach for disordered proteins can be employed as well. However, for
disordered proteins, globally defined axes of rotational diffusion are not well defined. Because of
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this, alternative models must be used to interpret the Δ𝑅2 values. More direct relaxation
approaches are also possible. For example, Xie et al. used an interaction model built up from
individual amino acids to describe the interaction of the transactivation domain of p53 with
SiNPs.113 This model, termed the free residue interaction model (FRIM), can be used to
determine which regions in a disordered protein are most favored to interact with a NP surface.
Because Δ𝑅2 values must be observable, this approach is again only suitable for monitoring
proteins interacting with NPs in fast exchange and is therefore limited to soft corona interactions.
Nevertheless, intrinsically disordered proteins (IDPs) and IDP regions make up a significant
fraction of the proteome,147-152 and the FRIM approach makes an important contribution in
understanding how these proteins interact with surfaces.

Figure 1.4

Use of PRE and chemical shift perturbation to investigate the orientation and
binding site of Ubq on paramagnetically doped fluoride-based SrF2 NPs.

(A) The site-specific chemical shift perturbation (CSP) observed for Ubq upon transient
adsorption to diamagnetic NPs. The diagram indicates that, for weakly associating proteins in the
soft corona, only residues near the interaction site are perturbed. (B) Residue-specific CSPs
observed for Ubq upon interaction with NPs. (CSP > 0.02 ppm are highlighted in blue). (C)
Large CSPs mapped on to the native structure of Ubq, revealing the interaction surface in blue.
(D) In the presence of a paramagnetically doped NP, proximity to the stable radical electron
induces relaxation in 1H spins. The diagram indicates that, in addition to experiencing CSP, such
spins experience additional line broadening. (E) Intensity ratio (I para / Idia) of peaks in the
presence and absence of a paramagnetic spin label. Lower intensities occur because of proximity
to the NP surface, corresponding to the interaction site identified by PRE. (F) Graphical
representation of Ubq Binding to SrF2 NPs. Reprinted with permission from Zanzoni et al.,127
copyright 2016 American Chemical Society.
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Paramagnetic Relaxation Enhancement (PRE) has emerged as an alternative, powerful
tool to investigate various dynamic processes involving macromolecules. The PRE-arises from a
dipolar coupling between nuclear spins and unpaired electrons, and it increases nuclear R2
relaxation with an r-6 distance dependence between the paramagnetic center and the nucleus of
interest.153 Typically, the nuclear spin of interest is a proton, as 1H nuclei are the most sensitive
to the relaxation enhancement. Quantitatively, the observed R2 relaxation (𝑅2,𝑜𝑏𝑠 ) can be
interpreted as 𝑅2,𝑜𝑏𝑠 = 𝑅2 + 𝑅2𝑃𝑅𝐸 , where 𝑅2 is the relaxation rate in the absence of PRE and
𝑅2𝑃𝑅𝐸 is the enhancement term. In the case of biomolecule-NP association, the observed R2 value
is ensemble averaged, complicating a strict interpretation of the r -6 distance dependence.153-154
For a static interaction, the PRE interaction range is limited to 25 Å, but this value will be
influenced by the population of NP-associated vs. unassociated proteins, as well as the density of
unpaired electrons on the NP surface. In practice, an intensity ratio is measured, comparing the
intensity of protein peaks with and without paramagnetically-doped NPs (Ipara / Idia, Figure 1.4);
in this case, Ipara/Idia, plotted against residue number, is interpreted semi-quantitatively, and it is
assumed that lower intensity ratios have a strong interaction with the NP surface. The PRE can
only be detected when the exchange is in the fast regime due to the intrinsic line broadening that
occurs upon long-lived adsorption to the NP.
PRE has been used on numerous occasions to identify protein orientation on NP surfaces.
Zanzoni et al. determined the Ubq interaction interface on paramagnetically doped fluoridebased (SrF2:Y3+,Gd3+) NPs using PRE. The residue intensities perturbed in the presence
paramagnetically labeled NPs were predominantly located in the stretches of residues 4-13 (β1
and β2), 44-55 (β3 and β4), and 63-76 (β5) (Figure 1.4E).127 In a similar study, Ceccon et al.
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used PRE to investigate Ubq on lipid-based nanoparticles (POPG-LUV), and they were able map
the binding site of Ubq on these Gd3+-paramagnetically tagged lipid-based NPs.43 They
concluded that the Ubq central hydrophobic region mainly interacts with the negatively charged
surface of POPG-LUV. Both groups identified similar binding sites Ubq on fairly different NPs,
suggesting that Ubq may have a common mode for binding to surfaces.
1.6
1.6.1

Results from Different Nanoparticle Systems
Noble Metal Nanoparticles (Gold/Silver)
Gold nanoparticles (AuNPs) are frequently used in NP-protein studies due to their low

toxicity and unique optical, chemical, and physical properties.155 Functionalization of AuNPs is
straightforward, leading to a broad diversity of surface behaviors and properties. Because of this,
it is challenging to generalize the behavior of biomolecule-AuNP association, and for any NP
system, subtle changes to surface chemistry can lead to large changes in binding behavior,
altering both the soft and hard corona composition and dynamics. Most proteins bind to AuNPs
spontaneously without causing any aggregation,48 and when aggregation does occur, hydrogels
can be used to maintain NPs in suspension.145 Thus, AuNPs provide a good platform to study
NP-protein interactions to gain insight on orientation, structure, and function of the protein.40,111
In this and the remaining sections of this review, we will briefly summarize several key
applications where NMR has been leveraged to understand how and why proteins interact with
NPs, starting with AuNPs.
AuNPs have displayed a variety of behaviors depending on surface functionalization, but
generally globular proteins interact with AuNPs in slow exchange with minimal structural
perturbation as measured by NMR. In the presence of 1.5 nm AuNPs, fibroblast growth factor
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(FGF1) exhibited a minimal perturbation of its secondary structure156 as monitored by NMR;
however, Ubq had a few residues in the N-terminus that exhibited chemical shift perturbation
upon binding, suggesting that, while both proteins interact with small nanospheres, Ubq exhibits
a site-specific preference in doing so.157 For larger AuNPs, early studies on Ubq suggested that
chemical shift perturbations were also present in the presence of 12 nm particles. 40 However,
chemical shift perturbations should be associated with an increase in linewidth (Figure 1.1), and
this was not observed. It was later proposed that an additional protein contamination or buffer
mismatch influenced the Ubq NMR spectra.111 Because AuNPs interact with DNA as well as
many proteins, molecules besides the target protein can influence NMR measurements of NP
binding. For studies of specific protein interactions, it is therefore important that the proteins
used are the highest purity possible and that the buffer conditions are well controlled.
Characterization by both 1D and 2D NMR spectroscopy suggests that Ubq and GB3 have
a site-specific orientation on 15 nm citrate AuNPs.39,111 In both of these cases, binding is in very
slow exchange, allowing the quantification of adsorbed protein. 111 It would appear that, for many
stable globular proteins interacting with medium size AuNPs (10-80 nm),85 monolayer binding
on the AuNP surface gives rise to a stable hard corona with little evidence for a dynamic, soft
corona. Unstable, non-globular proteins85 and intrinsically disordered proteins (IDPs)56,85 behave
differently, suggesting that these proteins have altered conformations on the AuNP surface. In
particular, Lin et al. used HSQC spectra to determine that the orientation of α-synuclein, an IDP,
can be flipped depending on the surface charge of the AuNP. 56 Meng et al. investigated the
potential difference between MTAB (Myristyltrimethylammonium bromide) ligands at the ends
and the sides of gold nanorods (AuNRs) using chemical shift perturbation and T2 relaxation.158
35

As compared to the spherical AuNPs, MTAB-AuNRs have two distinctly different chemical
environments (elongated sides and spherical ends) due to the rod-like nature of the nanoparticle.
Both 𝑇2 and 𝑇2∗ relaxation times were compared for different aspect ratios of MTAB-AuNRs.158
When the aspect ratio increased, the difference between 𝑇2 and 𝑇2∗ also increased, and from this
data, the authors concluded that the MTAB headgroup mobility depends on the nanorod aspect
ratio.
Understanding protein conformational change on AuNP surfaces is a major issue yet to be
resolved. NMR, when combined with molecular simulations, is an extremely powerful tool and
has produced promising results. For example, a combined molecular-dynamics NMR approach
was used to characterize the interaction between the fibrillogenic protein β2-microglobulin (B2m)
and 5 nm citrate-capped AuNPs. Peak intensity analysis of HSQC data revealed the presence of
CSPs for specific amides, especially those close to the N-terminus, when attaching to the AuNP.159
The small size of the AuNPs in this study allowed a direct comparison between simulations and
NMR CSPs, even though the binding was found to be in slow exchange. Ultimately, the B2m
protein attachment to AuNP did not disrupt the secondary structure nor lead to amyloid
aggregation,159 although simulations did identify that the citrate ions can alter stability by changing
the local pH.
Silver nanoparticles (AgNP) are another common noble nanoparticle with antibacterial
and antifungal properties.160-162 Protein interaction with AgNPs has been characterized through
CSP, NMR titrations, and relaxation-based experiments.163-164 AgNPs without any surface
functionalization were used in Ubq to observe several CSP changes in the amino acids of the βsheet region, suggesting this may be its interaction site. 164 Brahmkhatri et al. demonstrated that a
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conjugate of AgNP with Ubq is highly stable over a wide range of pH values compared to the
bare AgNP.165 Chemical shift perturbation was used to identify the Ubq residues responsible for
binding with AgNP and the NMR titrations were carried out to measure the dissociation constant
(KD).165 Pal et al. carried out a similar study to understand the structural and dynamic changes of
antimicrobial peptide Odorranain-A-OA1 (OA1) upon binding to AgNP.163 For this peptide, the
1D 1H spectrum indicated chemical shift perturbations upon binding indicating the peptide
interaction with AgNP. The specific residues interacting with AgNP were identified by acquiring
2D 1H -13C HSQC spectra.163 Most notably, the Cys 15 residue was perturbed due to the direct
interaction with AgNP. Generally, silver nanoparticles appear to have weaker protein binding
compared to AuNPs, and AgNPs can gradually undergo oxidative dissolution in biological
fluids, eventually dissolving while releasing soluble Ag+ ions.166-167 This reduced stability
appears to influence protein binding, leading to a more dynamic corona when observed by
NMR.165
1.6.2

Silica Nanoparticles
Silica nanoparticles (SiNPs) are inorganic nanoparticles with many applications ranging

from biosensors (optical properties) to drug delivery vectors (encapsulation capacity). 168-172 The
characteristic features of SiNPs are their low cost, low toxicity, and biocompatibility. 173 Several
groups have used NMR to investigate SiNP-protein interactions using a variety of proteins,
including lysozyme,174 carbonic anhydrase,42,175-176 fibrinogen,177 BSA,178 and cytochrome c.179
While a hard corona may form on SiNPs, 180 NMR studies generally find that proteins also
exhibit fast exchange behavior in the presence of SiNPs. Because of this fast exchange behavior,
solution NMR techniques have been used to monitor the CSPs in the presence of low
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concentrations of SiNPs.176 This has enabled the identification of residues interacting with SiNP
surfaces. Silica surfaces are generally negative, 181-182 as terminal silanol groups dissociate to
produce a negative charge. SiNPs have a negative zeta potential, 183 and it is not surprising
therefore that positively charged residues interact with the negatively charged SiNP surface. This
has been confirmed using the NMR-derived FRIM model, discussed above.113
While proteins may retain some native structure on SiNPs, NMR studies have suggested
that proteins tend to deform on these surfaces. For example, acylphosphatase (AcP) was
examined in the presence of 4 nm and 15 nm SiNPs, and HSQC spectra were used to examine
structural changes.184 It was found that, for both sizes, interaction occurred preferentially at the
α-helices in AcP. HSQC spectra indicated that only 15% of the peaks are affected by SiNPs, and
these residues were common to both 4 and 15 nm SiNPs. At the same time, enzymatic activity
experiments revealed that the protein lost activity on SiNP surfaces, and more activity was lost
on the larger 15 nm SiNPs. This suggests that a specific interaction is present, but that the protein
deforms once bound. A 2004 study focusing on carbonic anhydrase observed significant
broadening of the protein NMR signals in the presence of 6, 9, and 15 nm SiNPs. This
broadening increased over time and could be fit with a biexponential time dependence. The time
constants of the fast and slow phases were 5 h and 45 h, respectively, suggesting that, while the
protein interacts with the SiNP surface in fast NMR exchange, the nature of that interaction may
change over time.42 It was suggested that this slow change occurs during the formation of the
SiNP hard corona. Using supporting spectroscopic techniques, this study also found a trend
where increasing SiNP size resulted in an increasing perturbation to the protein secondary
structure.
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1.6.3

Carbon Based Nanoparticles
There are several different carbon-based nanoparticles, carbon quantum dots, carbon

nanotubes, and fullerenes.185-187 Understanding how biomolecules interact with carbon
nanostructures is important for a number of applications, including biosensing, and NMR has
seen some use in probing protein-surface interactions in this area. The principal challenge in
using NMR to study protein interactions with carbon-based NPs is the solubility in aqueous
media. One study was able to overcome this challenge by studying the small fullerene C60 (1 nm)
as it interacts with lysozyme.188 Lysozyme solubilizes C60, forming a stable 1:1 complex in
aqueous solution. Because C60 is comparable in size to a small peptide, NMR spectra can be
acquired directly with minimal line broadening, and CSPs can be measured in the complex.
Amino acid residues experience the largest perturbations close to the catalytic site of lysozyme,
suggesting that the protein interacts with C60 at that location. Another study overcame the
solubility issue by using polyhydroxylation of fullerenes. Zanzoni et al. used NMR to observe
the binding of Ubq to hydroxylated fullerenes.189 Based on CSP data and the intensity change
upon binding, the binding site of Ubq was identified a hydrophobic patch centered around Leu8,
Ile44, and Val70. 15N-R2 spin relaxation rate changes and DEST were used to characterize the
reversible formation of soluble aggregates upon protein binding to fullerene surfaces. No other
studies to our knowledge have explored biomolecular interactions with carbon nanomaterials
using NMR, but it is likely that these examples cover two extremes: On the one hand, bare
carbon nanomaterials are hydrophobic and will likely exhibit slow exchange behavior, as is seen
with lysozyme. On the other, adding solubilizing groups will make the surface more hydrophilic,
promoting faster exchange at the surface. It remains to be seen whether these observations from
39

NMR spectroscopy can be generalized to other structures, such as carbon nanotubes, and this
remains an area of active investigation.190
1.6.4

Polystyrene and Polymeric Nanoparticles
Polystyrene and other polymeric nanoparticles represent an extremely broad class of NPs,

and the variety of materials and surface functionalization used make generalizations challenging.
Here, we focus on polystyrene latex spheres, which are typically functionalized with either
amidine (basic) or carboxyl (acidic) groups to prevent aggregation in aqueous media. The first
notable example applying NMR to polystyrene NPs was in 2004 by Engel, et al.139 These
investigators examined the behavior of bovine alpha-lactalbumin (BLA) using HDX and found
that the protein adopts a molten-globular like structure on the surface of polystyrene NPs. They
found that the hydrophobic NP surface produced a stable hard corona, allowing HDX
measurements to occur on the NP surface itself. The observed NP-bound HDX rates were
compared to the molten globule rates for BLA, and the rates were observed to correlate. While
this would suggest a hard corona and slow exchange behavior, a recent study by Yang et al. used
saturation-transfer difference (STD) NMR to investigate the association between amino acids
and the polystyrene surface.191 STD NMR192-194 is similar to DEST in that off-resonance
saturation is used to monitor the strength of binding in an invisible, NP-bound state. Aromatic
amino acids exhibited the strongest STD effect, suggesting that significant π-π interactions can
occur between amino acid side chains and the NP surface. This hypothesis was confirmed using
sum frequency generation spectroscopy, a nonlinear optical method used to probe surfaces.
Together, these results suggest that polystyrene NPs strongly interact with proteins, causing their
deformation upon adsorption. Nevertheless, adsorption is likely characterized in its early stages
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by faster interactions as individual residues rapidly sample the hydrophobic surface. Thus, NMR
studies suggest that biomolecules on polystyrene NPs initially form a dynamic soft corona that
eventually hardens in to a hard corona under (very) slow exchange – an observation that agrees
with prior work on polystyrene and polymeric nanospheres.3
1.6.5

Liposomal Nanoparticles
Protein interactions with liposomes, lipid vesicles, and micelles have been extensively

studied using NMR spectroscopy. Liposomal NPs are relevant because of their similarity to the
plasma membrane and their applications in drug delivery.195-196 Protein-liposome interactions are
generally fast and dynamic on the NMR timescale and give rise to a measurable Δ𝑅2 , enabling
the application of DEST and other relaxation based methods. 119,144 As described above, Ceccon
et al. studied the interaction of Ubq with negatively charged and zwitterionic liposomes, and
relaxation fitting was used to identify the orientation axis on the NP surface.43 This work was
later extended to multidomain proteins, focusing on a covalent Ubq dimer. Additional theoretical
considerations are needed to handle binding in this case, and it was found that the linker
connecting Ubq molecules could influence binding for the distal Ubq domain. DEST studies of
protein-liposome interactions have also been informative. Investigations of fatty acid binding
protein have also been used to identify the interaction site with 90 nm liposomes consisting of a
1:1 ratio of palmitoyl-oleoyl-phosphatidylglycerol (POPG) and palmitoyl-oleoylphosphatidylcholine (POPC).43
IDPs or partially disordered proteins are also prone to lipid binding. The α-synuclein
protein (αS) is a water soluble, natively unfolded protein involved in Parkinson’s Disease, and
αS is in equilibrium between water soluble and membrane-associated states.197-199 Similarly,
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huntingtin is a protein involved in Huntington’s Disease, 200 and the poly-Q tails of this protein
are implicated in membrane association.201 NMR experiments have been used to study the αS
bound to small unilamellar vesicles (SUVs).198 Bodner et al. observed a decrease in peak
intensities, revealing that the N-terminal end of αS preferentially associates with the SUV. 198 A
related study examined the NMR signals originating from 31P nuclei in the vesicle and identified
a binding model with different distinct bound species of αS.202 More recently, investigations on
huntingtin-derived peptides have used chemical exchange saturation transfer (CEST) methods to
identify chemical shift changes in an otherwise invisible lipid micelle-bound state.116 These data
have been combined with experiments using pulsed EPR to study dimerization on the NP
surface, and kinetic rates for dimerization have been extracted for different lengths of poly-Q
tails. Thus, while introduction of protein disorder adds complexity to NP association, under
appropriate conditions NMR can be used to monitor surface folding and molecular interactions.
1.7

Conclusions
Solution NMR spectroscopy is a powerful tool for characterizing biomolecule-NP

association, owing to its ability to monitor structure, thermodynamics, and dynamics, often
simultaneously in the same experiment. When combined with other analytical and computational
techniques, protein surface interactions can be studied in great detail. Even simple 1D 1H-NMR
spectra in the presence and absence of NPs provide information on protein interactions, and
straightforward experiments involving quantitative NMR have been used effectively to
characterize the behavior of proteins upon adsorption. More sophisticated experiments involving
chemical exchange, HDX, and relaxation can complement this information, providing a nearcomplete picture of adsorbed protein behavior. At present, the main challenge is understanding
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how NP surface properties influence the type of behavior observed. For example, liposomal and
silica NPs exhibit dynamic protein binding behavior, suggestive of a soft corona, whereas other
NPs like citrate-capped gold and polystyrene NPs, appear to trap proteins on the surface for
extended periods of time, a key property of the hard corona. Each of these behaviors (fast vs.
slow vs. no exchange) will influence which set of experiments is most appropriate for studying
the system of interest. Thus, while current NMR approaches cannot in general measure signals
for surface-bound biomolecules, the development of indirect methods reviewed here has made
the study of protein-NP interactions quite tractable. As nanoparticles continue to proliferate in
biosensing and drug delivery applications, NMR will undoubtedly continue to be useful in
understanding how NPs interact with the components of biological fluids.
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CHAPTER II
STRUCTURE AND ORIENTATION OF A SMALL PROTEIN ON A NANOPARTICLE
SURFACE
2.1

Abstract
Nanoparticle technology has been a growing field in medical research. This is in part due

to potential applications in drug delivery, biosensing, diagnostics, and imaging. Understanding
the interactions, structure, and dynamics of biomolecules on nanoparticles is highly desirable.
Solution NMR can be used as a novel method of identifying characteristics of biomolecules
when they interact with nanoparticles. Our previous work suggests that the GB3 protein forms a
monolayer on gold nanoparticle (AuNP) surfaces and remains globular. We have employed
hydrogen-deuterium exchange (HDX) to probe the tertiary structure of GB3 when adsorbed.
Remarkably, highly protected residues on the AuNP surface are also highly protected in solution,
and there is a strong correlation between HDX rates under both conditions. The HDX rates of the
AuNP surface-bound protein were notably lower than the free protein in solution. These results
suggest that adsorption increases the stability of GB3 and that this protein retains its native
structure on the AuNP surface. The orientation of GB3 was determined by carrying out methyl
labeling of lysine residues. Lysine residues in the β-sheet region of GB3 were resistant to
methylation when bound to AuNPs, suggesting that these residues are buried at the NPbiocorona interface. This result is supported by competitive binding experiments, which
demonstrate that mutagenesis of β-sheet lysines significantly disrupts binding. The results
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reported here demonstrate that proteins can retain a stable, well-defined structure and orientation
when adsorbed to NP surfaces, and may be significant for the general study of biomolecular
protein corona.
2.2

Introduction
Understanding and modulating the binding of biomolecules to nanoparticle surfaces is

key for the advancement of biomedical sciences.1-6 The surface of nanoparticles (NP)
spontaneously adsorbs proteins from a physiological environment to form a protein corona.7-10
The nature of protein adsorption on NPs determines the protein corona, which controls the
cellular interactions determining the fate of NPs.11-13 The order of protein binding to NP surface
and the nature of the adsorbed proteins on NP are highly dependent on nanoparticle size, shape
and the surface chemistry.14-17 Elucidating the region of protein (i.e. protein binding region) that
preferentially interacts with nanoparticle surfaces is of high interest; as it can help explain the
final structure and orientation of the adsorbed protein.18-29 However, a detailed understanding of
these binding regions on bimolecular-nanoparticle interfaces remains limited, and new
biophysical approaches are needed to discover the details on structure and orientation of protein
on NPs.
Due to experimental difficulties, detailed information about structure and orientation of
proteins on NP surfaces is inadequate. Furthermore, existing methods are not capable of
elucidating protein binding regions while the protein is attached to the nanoparticle surface.
Recently, solution NMR spectroscopy has been employed to characterize protein-bound
nanoparticles. This technique is a highly advantageous and emerging tool, due to its many
advantages and diverse applications in studying a wide range of protein-nanoparticle
64

characteristics such as quantifying the amount of bound protein, local stability, dynamics, and
functionality of various active sites.7,30-37 Zanzoni et al., successfully used chemical shift
perturbation and paramagnetic relaxation enhancement (PRE) experiments to identify the
orientation of ubiquitin on NP surface38 and Wang et al., 2016 suggested electrostatic
interactions play a dominant role in protein binding to NP surface with the use of NMR
spectroscopy.39 These prior results demonstrate NMR spectroscopy’s ability to monitor specific
areas of proteins bound to nanoparticle surfaces.40-41 Hydrogen-Deuterium Exchange (HDX) is a
phenomenon based on the chemical reaction of replacing covalently bonded hydrogens with
deuterium atoms to reveal the tertiary structural information of proteins which can be observed
through NMR.42 HDX can be used as a probe to determine protein conformational dynamics and
interactions at a residual level. Heinrich Roder, et al used HDX to determine the protein folding
intermediates in cytochrome c.43 The use of HDX led to the identification of induced
conformational changes of bovine α lactalbumin bound to polystyrene nanoparticles in a study
by Engel et al, 2004.44These previous experiments suggest that HDX can be employed to
determine both the structure and orientation of protein on NPs.
Post translational modifications (PTM) can act as probes and help identify specific
binding residues and orientations of proteins. Reductive methylation of Lysine is a common in
vitro PTM, however, this method is difficult to use in AuNP studies since reductive reagents can
induce nanoparticle aggregation. Nevertheless, we have successfully incorporated Lysine
methylation by reductively methylating WT GB3, Bovine Serum Albumin (BSA), and mouse
immunoglobin G, which are stable proteins that are thoroughly characterized in solution to probe
protein binding to the AuNP surface.21,45-49 Serum Albumin and immunoglobin G (IgG) are the
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two most abundant proteins in human plasma and can be found in soft protein corona as well. A
study carried out by Shrivastava et al has shown that Lysine residues in the adsorbed surface of
Lysozyme are associated with a large decrease in acetylation compared to free Lysozyme in
solution. This indicates positively charged Lysine side chains are interacting with negatively
charged AuNP surface hence the electrostatic nature of protein is crucial for interacting with
AuNP.50-51 These experiments also demonstrate that in vitro PMT can be used to determine
which residues are involved in binding to NP surfaces. In this study, HDX by NMR
Spectroscopy, reductive methylation of Lysine, and competitive binding are collectively used to
determine the residual level structure and orientation of protein bound to nanoparticle surfaces.
2.3
2.3.1

Material and Methods
Synthesis of Citrate-Stabilized Gold Nanoparticles.
15 nm gold nanoparticles (AuNPs) were synthesized via citric acid reduction using

principles of the Turkevic synthesis method. Gold (III) chloride titrate and sodium citrate
dehydrate were purchased from Sigma-Aldrich. After 100 mL of 1 mM HAuCl4 had been heated
to boiling, 10 mL of 38.8 mM sodium citrate solution was immediately mixed with the gold
solution. This mixture was stirred on heat for an additional 20 minutes before being cooled to
room temperature. The cooled solution was then centrifuged for 45 minutes at 9000 x g. The
concentrated AuNP sample was then extracted and sonicated for 6 minutes (in 1-minute
intervals) at a power level of 1 on a Branson sonicator. The sonicated sample was assessed via
UV-Visible spectroscopy and transmission electron microscopy for size and conformity. For
AuNPs of this size it was expected that the maximum absorbance should be at 520 nm.65 From
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TEM it was found that AuNP samples created as mentioned above had a maximum absorbance
of 520 nm with an average diameter of 13 +/- 0.4 nm.
2.3.2

Protein Preparation and Methylation.
WT GB3 and GB3 variants were expressed and purified according to previously

published methods. 15N-ammonium chloride was added to M9 growth media in order to
isotopically label the protein samples for NMR analysis. Protein purity was established using
SDS-PAGE electrophoresis and the concentration of all proteins was measured at 280 nm
wavelength using UV-Vis spectroscopy. GB3 variants used in this study were created by sitedirected mutagenesis (Agilent) and verified by DNA sequencing and mass spectrometry. Bovine
Serum Albumin (Sigma) and mouse Immunoglobin (IgG) (Biocell) used for methylation studies.
2.3.3

Methylation of Protein.
Methylation of GB3, BSA, and IgG protein was carried out by reductive alkylation. 13C

Formaldehyde 4.0% (v/v) (Cambridge Isotope Laboratories) was added to a final concentration
of 0.16% in a solution of 0.5 mM GB3 in water at pH 7.0. The solution was then centrifuged at
1600 x g for 2 minutes after being inverted to mix the sample. Dimethyl borane was then added
to a final concentration of 25 mM. The solution was left to react at room temperature for 1 hour
before they were dialyzed against sodium phosphate (pH 7) buffer, and complete methylation of
GB3 was verified by mass spectrometry. BSA (data not shown) and IgG were run on SDSPAGE gels to verify the purity of proteins after methylation. Methylated BSA and IgG were run
on Superdex 200/10/300 analytical column to validate native molecular weight. Both analytical
and SDS-PAGE experiments confirmed the native structure of BSA and IgG after methylation.
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2.3.4

NMR Measurement of Protein Competition.
First 80 nM AuNP was incubated with 13C WT GB3 and the unbound protein removed

with consecutive three washes with sodium phosphate buffer. After that 13C WT GB3 bound
AuNP was resuspended in 15N-labeled WT GB3 labeled buffered solution same as the above
experiment. After one-hour incubation NMR half filter measurement was used to measure the
protein in solution. Same measurement was repeated after 18 hours.
Equimolar 15N-labeled WT GB3 and a 15N-labeled variant were mixed in pH 6.5 20 mM
sodium phosphate buffer. After adding 200 µM DSS as a quantitative standard and 6% D2O the
protein was mixed with AuNP which gave the final concentration of WT GB3, GB3 variant for
30 µM and 80 nM for AuNP. NMR spectra were obtained, and half-filter NMR experiment was
used for signal filtering of 15N and 13C -attached protons. For each data point three spectra were
recorded; one with no filter, 13C filter, 15N filter. Relative concentrations were calculated with
respect to the DSS peak which recorded without any filter.
2.3.5

Hydrogen Deuterium Exchange for Bound and Protein in Solution.
Hydrogen-Deuterium exchange rate for unbound protein was obtained by resuspending

lyophilized 15N-labeled WT GB3 in sodium phosphate buffered D2O at pH 6.5 (uncorrected for
D2O) for a final concentration of 500 µM. The final D2O percentage was 96% according to the
calibration plot. NMR samples were transferred to a 600 MHz Bruker Avance III cryoprobeequipped NMR spectrometer. The dead time between the addition of buffered D2O and first
NMR measurement was 5 mins. Series of 2D 1H-15N SOFAST HMQC spectra were recorded for
960 mins. The 15N acquisition time for each experiment was 50 ms, collected over 512 complex
time points. The total experiment time for each experiment was 1 min and 59 secs.
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The exchange rate for WT GB3 bound to AuNP was obtained by following steps. 30 µM
of 15N WT GB3 was incubated overnight with 150 nM AuNP phosphate buffered solution at pH
6.5 to saturate the AuNP surface with WT GB3. The solution was centrifuged at 9050 rcf for 5
mins to pellet the AuNP and remove the supernatant to get rid of all unbound protein. Separate
1D proton NMR spectra and SDS-PAGE gel experiments were carried out to confirm that there
was no unbound protein in the solution. The AuNP pellet saturated with WT GB3 was
resuspended and incubated in D2O for 30, 90, 180, 360, 720 mins. After each time point, 200 µM
DSS, 2 mM MBI (in D2O) and DCl at pH 2.5 was added for a final volume of 500 µL to displace
the protein from AuNP surface and quench the exchange reaction. 1D proton NMR and 1H -15N
HSQC spectra were collected to obtain the amount of displaced WT GB3 and monitor the
exchange rate.
HSQC spectra were processed using NMR pipe and the chemical shift assignment for
GB3 was obtained from previous studies. The backbone chemical shifts for residues of WT GB3
at pH 2.5 were obtained by HNCA and standard HSQC NMR spectra (Figure 2.1A). The real
time HDX measurements were obtained by normalizing the intensities of each cross peak by
dividing it with the concentration of kicked of WT GB3 concentration. Then the time dependent
behavior of each peak I (t) was modeled by an exponential decay with a baseline offset.

I (t) = I0e –kt + b

(2.1)

In this equation, k is the observed hydrogen-deuterium exchange rate, b is the baseline
offset, included to account for any H2O in the solution. Value for k was given by the average of
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independent triplicate samples. Error bars were obtained from the standard deviation of triplicate
samples.
2.3.6

Methylation of AuNP Bound Protein.
As mentioned in the above hydrogen-deuterium experiment, AuNP surface was saturated

with WT GB3 and made sure that no unbound protein in the solution. WT GB3 bound AuNP
was resuspended in 100 µL water at pH 6.5 and 4.0% (v/v) 13C formaldehyde was added to a
final concentration of 0.16%. After mixing by inversion, the reducing agent dimethyl borane was
added to the AuNP-protein solution to a final concentration of 10 mM. The reaction was
incubated at room temperature for 6 hrs and displace the bound protein by adding 2 mM MBI.
The protein solution was centrifuged at 9050 rcf for 5 mins to remove the AuNP and extensively
dialyzed against water. 1H -13C HMQC NMR spectrum was obtained for the phosphate buffered
sample at pH 6.5 for a final volume of 500 µL.
2.3.7

H2O Percentage through Calibration Plot
Calibration samples were made by mixing H2O and D2O in following ratios: 2:98, 4:96,

6:94, 8:92, 10:90, 20:80, 40:60, 50:50, 60:40, 80:20, 90:10. The reference sample was 50:50
C6H6:C6D6. The reference was used as an external standard. A special NMR tube, which has a
narrower bottom was used to put the reference sample inside the normal NMR tube. Bruker
AVANCE III 300 MHz NMR spectrometer was used to obtain the 1D NMR spectra. The H2O
peak was integrated with reference to the C6H6 peak. The integrated peaks were obtained for all
the samples mentioned above and generated a calibration curve.
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2.4

Results and Discussion
Protein molecules spontaneously adsorb on nanoparticle surfaces in solution and will not

dissociate for long periods of time unless a competitive molecule is added, the pH is changed, or
the salt concentration is altered.52-53 Our study focuses on protein forming hard corona, since
proteins on hard corona will reach the compartments in human body without desorption which is
useful in biomedical studies.54 The uncertainty of protein desorption was investigated by
carrying out a simple experiment. If the two proteins are in dynamic equilibrium on the AuNP
surface, the protein already adsorbed on the AuNP surface should have formed a hard corona and
should not be replaced by new protein. To test this hypothesis, the AuNP surface was incubated
with 15N WT GB3 to saturate the surface before adding 13C WT GB3 to the solution. The
adsorption of each labeled protein was quantified independently using NMR half filter
experiments after 1-hour and 18-hour increment. The results show that, after 18 hours of
incubation, 13C WT GB3 did not displace the bound 15N WT GB from the surface. The result
suggests GB3 forms a hard corona on AuNP.
In 2004, a study was done by Mierlo et al. that characterized the conformational
heterogeneity of the bound state of proteins to nanoparticles.44 By employing a series of HDX
experiments, we have characterized the structure of protein attached to AuNP surfaces and
determined that it forms a hard corona. If the bound protein deviates from its native structure on
the AuNP surface, the exchange rate of buried residues would differ significantly from the free
protein in solution; suggesting that bound protein has unfolded on AuNP surface. The buried
residues would be exposed to D2O and have elevated exchange rates. Thus, by comparing the
exchange rate of residues in AuNP bound and unbound states, protein structural changes on the
AuNP surface can be monitored. A 1H-15N HSQC NMR spectrum can be used to measure the
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HDX rates of individual residues. This allows HDX rates of adsorbed proteins to be compared to
their solution state counterparts.

Figure 2.1

The 2D NMR spectra and the H2O:D2O calibration plot.

(A) Assigned 1H-15N HSQC spectra for WT GB3 at pH 2.5. (B) The calibration plot for
determining the H2O percentage. The integrated peak ratio was obtained with respect to 50:50
C6H6:C6D6.
GB3 contains slow exchanging amide protons and, when the protein is folded in solution,
the backbone and buried residues are protected from HDX.14 HDX occurs when a protein
deviates from their native structure and D2O can access the amide backbone. GB3 protein was
incubated in phosphate-buffered D2O (~96% D2O) at pH 6.5 to obtain the exchange rates of
unbound protein. In solution, the D2O content of the sample was determined using a calibration
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plot. The HDX range is from 0.1x10-2 to 0.5x10-2 min-1, the residues that exchanged faster than
this did not appear in the HSQC NMR spectra.14 The SOFAST-HMQC55 NMR experiment was
used to determine the exchange rates ranging from 0 to 960 min. The HDX rates were extracted
from HMQC spectra by fitting intensities to a mono-exponential decay. The α helix residues, and
most residues in β sheet regions, were protected against D2O (Figure 2.2B). The residues A26
and F30, since they were buried inside the α helix, had HDX rates of 0.0671 min-1 and 0.0103
min-1, respectively. This indicates slower decay, compared to other residues, since they are
buried inside the alpha helix.

Figure 2.2

Evidence for slower kinetics of protein on AuNP surface and use of hydrogen
deuterium exchange to monitor the protein structure on AuNP surface.

(A) The correlation plot of HDX rates of WT GB3 in solution and bound to NP. (B) The
protection factor of AuNP bound state differentiates K4 and K13 residues which are 10-fold
protected, compared to other residues in the β sheet region.
The exchange rate of the bound protein was obtained as described in methods. The AuNP
surface was saturated with 15N GB3 and incubated in phosphate buffered D2O at pH 6.5 for time
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points ranging from 30 to 720 mins. At the end of each time point, the pH was reduced to 2.5
using DCL/D2O, and the bound protein was dissociated from the AuNP surface via the addition
of MBI in D2O. Payne, C. K. et al, 2014 employed similar methods to remove protein from
nanoparticle surfaces and confirmed removal via SDS-PAGE gel.56 The dissociated protein
solution was then centrifuged to pellet the AuNPs, and the supernatant was extracted and topped
off to 500 µL. The final concentration of added DSS was 200 µM. The D2O percentages were
determined using calibration plots (Figure 2.1B). The intensities from HSQCs were fit to monoexponential decay plots (Figure 2.1B). With the exception of residues 8-24, the exchange rate of
all the other residues in the secondary structure was obtained due to the fact that 8-24 residues
were in fast exchange with D2O. The HDX rates of adsorbed protein were significantly lower
than the unbound protein (since proteins bound to AuNPs were protected from D2O). When the
residues of GB3 (which were in solution and adsorbed to AuNP) were compared, the majority of
the residues in the loops and the β2 strand were completely exchanged with D2O (Figure 2.2B).
The same residues appeared in the bound GB3 with a few exceptions (e.g. residues G38, G48,
and E56). The HDX rates of unbound and bound GB3 were compared using a correlation plot
(Figure 2.2A). Surprisingly, the residues of WT GB3 (which show slower exchange in solution)
also exhibited slow exchange when adsorbed. The protection factor for both states was
measured (Figure 2.2B). The residues, K4, A26, A29, F30, Q32, Y33, D36, N37, and K50 were
protected 10-fold; compared to other residues. The residues A26, A29, F30, Q32, Y33, D36, and
N37 are located in an α helix region where they can be protected from D2O. The protection
factor is inherently increased for the residues in α-helix due to steric hindrance (Figure 2.2B).
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Figure 2.3

The relative peak intensities and concentrations of Lysine methylation and
competitive binding experiments.

(A) Methylated WT GB3 on AuNP surface and the relative methylated Lysine peak intensities of
AuNP bound methylated WT GB3 and in solution. (B) Relative bound concentrations of GB3
variant competing with WT GB3 in same solution with AuNP. (C) 1H-13C HSQC spectrum of a
selected methylated WT GB3 peaks in solution overlaid with AuNP bound methylated WT GB.
K13 peak is missing from the spectrum indicating its involvement in AuNP binding. Complete
1
H-13C HSQC spectrum is available in supporting information. (D) The relative peak intensities
of IgG protein when methylated IgG in solution compared with IgG bound to AuNP surface.
The triangle at 13th position indicates a larger peak ratio and error bar due to a weak intensity in
one triplicate.
These residues are two of the three residues (K4, K13, and K50) identified in our
previous work39 that can potentially interact with the AuNP surface. We believe the elevated
protection observed for these two residues, even when they are in the β sheet region, is due to the
attachment on AuNP surface. Notably, residue K13 does not show up in the bound protein at all
indicating faster exchange (i.e. not observed in HDX time scale). While K13 appears close to the
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β sheet region, it seems to hold more flexibility than other residues in the β sheet regions. Few
residues close to the C terminal, namely T51, F52, and T53, were not protected from HDX and
show negative protection factors (Figure 2.2B). This may be due to the fact that the C-terminal
strand is loosely attached to, and shows more mobility on, the AuNP surface.
Our HDX data suggests a native-like conformation for GB3 on the AuNP surface. To
obtain the specific orientation of GB3 protein we used Lysine methylation. The orientation of
bound GB3 was further confirmed via invitro PTM, methylation57-58 Methylation of GB3 protein
was performed by reductive alkylation using 13C formaldehyde and sodium cyanoborohydride as
the reducing agent.59 We hypothesized that Lysine residues that were binding to the AuNP
surface would be protected from methylation since they were not exposed to solvent. As a
control, WT GB3 was fully methylated, vide supra, and the methylated Lysine residues were
identified using previously created mutants.39 1H -13C –HMQC experiments were used to observe
the reductively added 13C-methyl groups. In the 1H -13C HMQC NMR spectra, two peaks appear
for some Lysine residues since these groups are chemically but not magnetically equivalent. This
is further explained by those residues having half the peak intensity of residues which have a
double- peaks (Figures 2.3C). A corresponding methylation process for GB3 bound to AuNP
was also performed. After displacing GB3 from AuNP 1H -13C HMQC spectra were utilized to
study methylated lysine residues on the AuNP surface. The methyl peaks, which are now missing
compared to the WT GB3, correlate with residues that were once considered responsible for
binding with the AuNP surface (Figures 2.3C). Namely, the K13 peak disappeared on the bound
protein compared to GB3 in solution, and these Lysine residues were the ones identified from
competitive binding and HDX protection factor. K4 and K50 peaks still appeared in the
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spectrum, we believe this is due to the fact that methylation timescale may not be enough to fully
capture the diminishing of peaks. When the peak intensities of AuNP bound and WT GB3 were
compared, we identified that K4 and K50 residues had reduced intensity compared to other
residues (Figure 2.3B). From these results, we can conclude that protein binding could be
modulated through post-translational modification.
After using GB3 as a model protein to validate protein-orientation on gold nanoparticle
surfaces, we examined (BSA) and mouse IgG; as both are physiologically relevant proteins.
Among all proteins in serum, albumin is the most abundant fraction (accounting for ~ 60% of the
total protein in solution (~1mM) by mass), globulin is the second most abundant (accounting for
the remaining ~ 40% mass), and all the other proteins make up ~ 1%. Previous studies stated that
both BSA and IgG bind to AuNP surfaces through electrostatic interactions in an oriented
manner.47,49,60 BSA and IgG were both methylated on the AuNP surface using previously described
methods. When 1H -13C HMQC spectra of methylated BSA on AuNP surfaces were compared to
methylated BSA in solution, we observed that peaks in the outer periphery began disappearing
which indicated Lysines were binding with the AuNP surface. At this point, we were unable to
assign the Lysine peaks using site-directed mutagenesis due to the size constraints of BSA. The
peak disappearance is a clear indication that the solvent-exposed Lysines of BSA are involved in
binding to the AuNP surface. To demonstrate the applicability of Lysine methylation to a wide
range of proteins, we tested IgG methylation on AuNP surfaces. IgG antibody is composed of two
heavy chains (430 residues) and two light chains (~210 residues). The radius of gyration for IgG
was ~5.6 nm and the molecular weight was ~155 kDa; meaning that fewer proteins are binding to
AuNP surface. A higher concentration of bound IgG was achieved using 30 nm AuNP for the
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methylation experiment. We believe that 30 nm AuNP size favors binding of the heavy chains;
which is the “end on” binding of IgG on surfaces. 61 It was recorded that IgG loses its ability to
bind antigens when the AuNP size is >20 nm.61 Previously, no study has been carried out to record
the 1H-13C HMQC of in vitro methylated IgG. In this study, the 1H -13C HMQC spectra were
collected for both IgG in solution and bound to AuNP. We believe that most dynamic Lysines in
the IgG are appearing in the 1H -13C HMQC spectra. When 1H -13C HMQC spectra of IgG in
solution and IgG bound to AuNP were compared, few peaks disappeared from the spectrum. Then
we compared the peak intensities to identify that some peaks show significant reduction in the
intensities (Figure 2.2D) (peaks are assigned with arbitrary numbers). 13th residue had a higher
relative peak ratio and error bar due to the lower intensity in one of the triplicates (Figure 2.2D).
This again validates our hypothesis that solvent accessible Lysines are responsible for protein
attachment with AuNP surfaces. For the first time, Lysine methylation was utilized to identify the
binding residues of larger and physiologically relevant proteins like BSA and IgG.
To confirm the orientation obtained from methylation experiments, we performed
competitive binding experiments to monitor relative importance of each Lysine residue. Lysine
residues are important in making electrostatic interactions with the AuNP surface. 62 We
previously identified the electrostatic nature of the binding and GB3 binding region to AuNP
surface by site-directed mutagenesis.39 K4, K13, and K50 residues were identified as the main
residues responsible for binding. From this information, we concluded that the β sheet region
was oriented towards the AuNP surface. This residue specific, electrostatic charge dominate
interaction, was further explored by Rafael Brüschweiler et al identified that positively charged
residues were interacting with the nanoparticle surface.63 Competitive binding allows two
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proteins interacting with AuNPs, to be monitored simultaneously. To achieve this, 13C-labeled
WT GB3 was mixed with an 15N-labeled GB3 variant in the same solution of AuNPs to monitor
the competition between the two protein variants. Each of the seven WT GB3 Lysine residues
were mutated to Alanine using site-directed mutagenesis.39 Since Lysine was believed to be
involved in surface interactions, the Lysine to Alanine variants competed less favorably against
WT GB3. Three residues, in particular, had significantly lower bound concentration than WT
GB3 in the same solution. The binding concentrations were lower for residues K4, K13, and K50
(Figure 2.2D). These same residues were predicated by Lysine methylation and found to be poor
competitors when mutated into Alanine. These findings are in agreement with our previously
published work where we predicted the binding residues and orientation.33 The specific
orientation of proteins was studied by Feng Liu, et al, 2015 through enzyme activity of E. coli
inorganic pyro-phosphatase. The orientation of the enzyme at the interface determines the
relative position of the active site with respect to the NP surface, which determines the
functionality of the enzyme.64
2.5

Conclusion

In summary, for the first time, NMR spectroscopy has been applied to address the key question of
protein orientation and structure on the gold nanoparticle surface. Using chemical methylation and
retained structure on AuNP surface by hydrogen-deuterium exchange, our data suggests a precise
orientation of WT GB3 on the nanoparticle surface. The observed exchange rates for AuNP bound
WT GB3 was slower compared to WT GB3 in solution, and the same residues experience similar
protection (albeit, at a slower rate), strongly suggesting that the structure of WT GB3 has been
retained on the nanoparticle surface. Protein orientation was further investigated through chemical
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methylation and competitive binding. The residues responsible for binding WT GB3 to AuNP
surface were consistent in all studies, including HDX protection factor, chemical methylation, and
competitive binding; all of which implicate the β sheet region. We believe that the approaches
taken herein constitute a novel way of investigating the structure and orientation of more
physiologically relevant proteins on nanoparticle surfaces.
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CHAPTER III
SURFACE FUNCTIONALIZED GOLD NANOPARTICLES
3.1

Abstract
Adsorbing enzymes to nanoparticles yield potentially new perception for nanoparticle

applications in medicine. Enzymes are involved in virtually all biological processes resulting in
many opportunities for bioconjugation with nanoparticles once nanoparticles are present in the
biological system. However, an enzyme adsorption process could compromise the functionality
of the enzyme by causing the enzyme to adopt an inactive conformation. For this reason, we
have focused on optimizing the orientation and the accessibility of the active site to a substrate in
solution when the enzyme is bioconjugated to the nanoparticle surface. Here, we describe a novel
construct of an enzyme attached to a base protein that can bind to gold nanoparticle (AuNP) by
forming a gold-sulfur (Ag-S) covalent thiol bond. The enzyme under investigation is human
carbonic anhydrase II (HCA II), which provides the enzymatic activity, and the base protein,
GB3 mutant, which provides a stable conjugation with AuNP via thiol bonding. We show that
HCA II was conjugated onto the AuNP with the GB3 mutant, without compromising the
functionality of the enzyme. Our novel method was successful in overcoming the molecular
crowding on the nanoparticle surface, as well as maintaining the enzyme’s (or protein’s)
orientation, structure, and active site exposure.
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3.2

Introduction
The interaction studies between inorganic materials and biomolecules (proteins, enzymes,

DNA, etc.) or drug molecules play a crucial role in understanding cellular signaling, specific
antigen targeting, therapeutics, and gene editing.1-6 Understanding these interactions may lead to
many applications in medicine, especially in the area of drug functionalized noble metal
nanoparticles, such as gold and silver, and their alloys using enzymes. 7-9 The potential
applications for these functionalized metal nanoparticles are currently driving the medical field
towards the fabrication of bioactive and biocompatible nanomaterials.10 However, it is known
that in the formation of these protein-nanoparticle (P-NP) complexes, the structure of the bound
protein may deform resulting in a loss of protein function. 11-12 This deformation has also been
shown for DNA as it approaches and binds to solid surfaces. However, recent studies have
shown that some proteins undergo minimal structural and functional changes once adsorbed to a
nanoparticle’s surface.13-19 For example, it has been shown that some antibiotic drug molecules
may have enhanced antibacterial activity, extended shelf life, and increased bioavailability once
they are tagged with a nanoparticles.20-21 These improvements are believed to be due to both
conformational and electronic changes in the drug molecule’s local environment.
Among all biomolecules, enzymes potentially have the widest range of applications
stemming from their wide range of physical and chemical properties. The fundamental task of
enzymes is to act as a biological catalyst in order to increase the rate of all chemical reactions
that occur within a biological system. In the absence of enzymes, most biological reactions are
many orders of magnitude slower. As a result, these reactions would not occur to the extent
required by the system for homeostatic maintenance under these physiological conditions. Cells
contain thousands of different enzymes and each of which have their own activities that
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determine which chemical reactions will be favored within the cell. The ability of nanoparticles
to travel to the inside of cells provides a powerful tool for the transportation of therapeutic
molecules. Some enzymes (e.g., glucose oxidase, cholesterol oxidase, IgGs) are covalently
immobilized on nanoparticle surfaces for their use in clinical applications and biosensors.22-26
However, a major challenge with these binding techniques is the potential for losing enzymatic
activity upon adsorption to the surface of the nanoparticle. 12,27-28 This loss in enzymatic activity
results from the change in protein tertiary structure, which alter the native characteristics of the
protein as well as the rate of substrate diffusion.
Nanoparticles can be functionalized by covalently binding enzymes to the surface of the
nanoparticle.29-30 This binding allows the nanoparticle to easily transport the bound enzymes to a
variety of cell lines. The functionalized nanoparticles have the ability to avoid endosomes and
have shown little to no cytotoxicity. This technique allows the enzymes to be introduced to
specific targets such as cancer cells in a rapid and controlled manner. The main obstacle to
successfully transporting enzymes to specific intracellular targets has been the poor membrane
permeability of enzymes. One proposed strategy has been to attach cell penetrating peptides to
enzymes by genetic or chemical modification to promote the translocation across plasma
membrane. Recently, nanomaterials including silica nanoparticles, AuNPs and carbon-based
nanoparticles have been shown to be an effective mode for protein delivery across the cellular
membrane. Functionalization of nanoparticles by both covalent and noncovalent attachment of
an enzyme has been challenging due to the potential loss of enzyme function due to the enzyme’s
orientation on the nanoparticle’s surface or the loss of tertiary structure once bound. 19,31 AuNPs
are a promising candidate for medicinal applications due to their bio-inertness and nontoxicity.32
89

Previous studies have shown that cells show little toxicity when introduced to 20 nm AuNPs.
AuNPs have been highly characterized to study the size, shape, surface charge, and functionality
of the nanoparticles.33 AuNPs are the colloidal suspension of gold constructs in the nanometer
size range. The most common sizes are varying from 10 nm to 100 nm. AuNPs can be
synthesized by utilizing an array of methods, but the most common method is the reduction of
chloroauric acid by a stabilizing agent to get the desired size and shape of the nanoparticle. The
large surface area and tunable surface chemistry of AuNPs make them an excellent construct for
protein surface recognition. The surface to charge ratio preserves the protein monolayer so that
bound proteins are able to retain their native conformation.
The most common methods used to study enzymatic activity on AuNP surface are
enzyme assays that utilize spectroscopic techniques such as UV-Vis, fluorescence, and mass
spectroscopy. Once enzymes are bound to the nanoparticle surface, the enzyme’s structure can
deform which can alter its activity. The enzyme’s orientation on the surface can also affect a
substrate’s access to the active site, which may prohibit enzymatic activity. Sometimes loss of
enzymatic activity is due to biomolecular crowding on the nanoparticle surface hindering the
substrate reaching the active site or causes the active site to be buried among other biomolecules
present on the nanoparticles surface. Due to these reasons, it is important to focus on the
protein’s orientation, as well as the active site’s accessibility upon binding to a nanoparticle. This
is particularly important in potential therapeutic uses of nanoparticles like those intended for
drug delivery but fail to exploit their clinical potential.34-35 A variety of protein conjugation to
AuNP surface methods are currently in use, such as covalent linkage, hydrophobic-hydrophilic
interactions, electrostatic interactions, and click chemistry.36
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In the current study, we report the synthesis of an HCA II enzyme attached to a stable
base protein with a linker. HCA II is a well-studied, robust, metalloenzyme that serves as an
excellent biological ligand system to study the enzymatic activity using colorimetric means.
HCA II catalyzes the reversible hydrolysis of carbon dioxide (CO2) into the bicarbonate ion
(HCO3-). Catalytic hydrolysis of CO2 is challenging to measure effectively in vitro, so as an
alternative enzyme activity assay, hydrolysis of p-nitrophenol acetate (4NPA) to 4-nitrophenol
(4NP) and acetic acid can be used to measure the relative enzymatic activity with visible
spectroscopy. The change in adsorption at 404 nm is related to the production of 4NP, which can
be interpreted using Michaelis–Menten enzyme kinetics. The base protein GB3 is a highly stable
and well-characterized small (6.2 kDa) protein. A cysteine residue replaces Asparagine at the 8th
position where the first beta-sheet starts. The cysteine will covalently attach to the AuNP surface
andHCA II will be exposed to the solvent by a linker. Using this novel method, for the first time,
we have eliminated all the obstacles faced when functionalizing nanoparticles including
orientation, structure, surface crowding, and function retention. Our construct has a TEV
cleavage site located between HCA II and linker regions to modulate the function of HCA II on
AuNP surface. In this paper, we have used a colorimetric assay using (4-NPA) to investigate the
enzymatic activity of HCA II on nanoparticle. First, we measured the bound concentration of
functionalized protein on the nanoparticle using 1D NMR. The activity of HCA II in the free and
bound states were measured and compared using the 4-NPA colorimetric assay. The HCA II was
cleaved by using TEV protease while bound to AuNP to demonstrate the enzyme activity
modulating capability of our construct. Below, we present the preparation of HCA II enzyme-
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containing construct and our results with a colorimetric assay to study the enzymatic activity of
HCA II functionalized AuNP.
3.3
3.3.1

Material and Methods
Synthesis of Citrate-Stabilized Gold Nanoparticles
15 nm AuNPs were synthesized via citric acid reduction using principles of the Turkevic

synthesis method. Tetrachloroauric Acid (HAuCl4) and sodium citrate dihydrate was purchased
from Sigma-Aldrich. After 100 mL of 0.3 mM HAuCl4 had been heated to boiling, 2 mL of 34
mM sodium citrate solution was immediately mixed with the gold solution. This mixture was
stirred with heat for an additional 20 minutes before being cooled to room temperature. The
cooled solution was then centrifuged for 45 minutes at 9000 x g. The concentrated AuNP sample
was then extracted and sonicated for 6 minutes (in 1-minute intervals) at a power level of 1 on a
Branson sonicator. The sonicated sample was characterized via UV-Visible spectroscopy and
transmission electron microscopy for size and conformity. For AuNPs of this size, it was
expected that the maximum absorbance should be at 520 nm. It was found that AuNP samples
created as mentioned above had a maximum absorbance of 520 nm with an average diameter of
13 +/- 0.4 nm.
3.3.2

Construction of Plasmid
The fusion protein consists of three different sections; GB3 variant, a linker, and Human

Carbonic Anhydrase. The GB3 variant was created by mutating N8C in order for GB3 to form a
covalent bond between the 8th residue and the AuNP surface. pET-15b vector was used to
subclone the DNA of interest. The plasmids in this study were designed for protein expression
under the control of the T7 promoter. The DNA was ligated into pET15-b bacterial expression
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vector containing a T7 promoter and an N-terminal 6x His tag sequence via Ndel and Xhol
restriction sites. The plasmid construction was done by Thermo Fisher Life Technologies.
6xHis-Tag was introduced in order to purify the protein using affinity chromatography. A
TEV cleavage site was included in order to cleave the linker region of the HCAII-GB3 fusion
protein. Human carbonic anhydrase was attached to the C terminal of N8C GB3. The linker
region (GGGGSGSAGSEAAGSEGSAGSEAAGSEGGGGSENLYFQSGSHMAS) was
designed so that it has flexibility and length to keep the human carbonic anhydrase away from
the mutated GB3 protein corona. After designing the fusion protein Thermo Fisher Life
Technologies was used to subclone the DNA into pET-15b vector.
3.3.3

Protein Expression and Purification
HCA was overexpressed and purified from the pACA plasmid in E. coli BL21(DE3) cells

as previously described.37 The HCA II fusion plasmid was transformed by heat shock into
competent cells BL21 Star (DE3) (Invitrogen) cells. The transformed cells were incubated in 50
ml M9 media (100 mg/ml ampicillin) overnight at 37 °C. These starter cultures were then added
to 1L of M9 minimal media (containing 100 mg/ml ampicillin). The starter culture in M9 was
used to inoculate the larger 1L M9 media such that the initial OD600 was 0.05. This larger culture
was incubated at 37 °C in a 200-rpm shaker. When the culture reached an OD600 of 0.5–0.7,
expression was induced with a final concentration of 1 mM isopropyl β-D-1thiogalactopyranoside (IPTG) and harvested after 6 h. Cells were pelleted by centrifugation for
30 min at 8000×g, and then re-suspended in lysis buffer (50 mM NaCl, 20 mM HEPES pH 6.5,
20 mM Imidazole, 1 mM DTT, 0.5 mg/mL lysozyme). The re-suspended cells were sonicated on
ice in a Branson Sonicator 250 at power level 6 for 3 repetitions of a 2 min pulse/2 min rest. The
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processed lysate was centrifuged at 18,000×g for 45 min at 4 °C, with HCA II fusion remaining
in the soluble fraction. The HCA II fusion was purified on a HisTrap FF column (GE Life
Sciences) using an imidazole gradient buffer. The HisTrap FF column was equilibrated with five
column volumes (CV) of washing buffer (50 mM NaCl, 20 mM HEPES pH 6.5, 20 mM
Imidazole, 1 mM DTT) at room temperature. HCA II fusion protein bound to HisTrap FF
column when loaded with wash buffer. The protein was eluted with a linear gradient from 0 to
100% elution buffer in 10 mins with 50 mM NaCl, 20 mM HEPES pH 6.5, 800 mM Imidazole,
and 1 mM DTT. Then, the purified protein was dialyzed with Thrombin to cleave the His-Tag in
wash buffer at 4oC overnight and Benzamidine beads were used to remove His-Tag bound
Thrombin. The final purification was performed with a HiLoad 26/600 Superdex 75 pg gel
filtration column (GE Life Sciences) equilibrated with 5 CV of wash buffer. The protein elution
was pooled (where the absorbance at 280 nm was higher than at 260 nm) and dialyzed in dialysis
buffer (50 mM NaCl, 20 mM Tris pH 6.5, and 1 mM DTT) overnight. The molecular weight and
purity of the HCA II Fusion were confirmed by SDS-PAGE. The GB3 null fusion and HCA II
null fusion proteins were purified using the above-mentioned steps.
3.3.4

NMR Characterization
The 15N labeled protein was expressed in M9 minimal media using 15NH4Cl as described

previously. 1H-15N HSQC was obtained for the fusion enzyme and compared with the 15N
labeled N8C GB3 and HCA II individual proteins. The binding capacity of the fusion protein and
N8C GB3 was calculated using a previously described method.38
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3.3.5

Catalytic Activity
The enzymatic activity assay was carried out using a 4-NPA hydrolysis assay. To ensure

the uniform Zn2+ metal binding, all metals present in the isolated protein were chelated using
dipicolinic acid (DPA) by dialyzing the purified protein overnight against 50 mM HEPES buffer
containing 50 mM DPA to generate metal free HCA II fusion. This apo HCA II fusion then
dialyzed in 20 mM HEPES buffer (pH 7.4). The p-nitrophenol (Sigma-Aldrich) solution was
made by dissolving solid 4-nitrophenyl acetate in acetonitrile. The molar extinction coefficient of
the p-nitrophenol at 404 nm was defined to be 18 400 M-1cm-1. Before running the sample, 4-NP
absorbance was calibrated using constant concentration HCA II enzyme, and a series of 4-NPA
concentrations. The buffer components were 20 mM HEPES and 50 mM NaCl. Samples with 20
mM 4-NPA/acetonitrile, 3 µM HCA II fusion, and 20 mM ZnSO4 were made with a final
volume of 500 µL. The absorption was measured at 404nm for 10 mins with 8 sec intervals with
increasing substrate concentration. The slopes of each curve were fitted to get the initial rate at
each of the substrate concentrations. The Km, Vmax, and kcat were obtained by fitting the values to
the Michaelis-Menton equation using an in-house developed script. The nanoparticle bound
HCA II fusion protein samples were prepared by incubating 5 µM enzymes with 30 nM AuNP
for 1 hour and then centrifuged at 12 000 x g and washed three times in order to remove the
unbound enzyme present in solution. The pellet was then resuspended in the same buffer and the
4-NPA and ZnSO4 were added to a final volume of 500 µL. The dead time for both experiments
was 1 min.
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3.3.6

Modulating Protein Activity on AuNP
The TEV cleavage site in the HCA II fusion protein was tested by dialyzing the enzyme

in Tris-NaCl buffer (0.5 mM TECEP) with equimolar TEV protease in 4oC for 16 hours. The
AuNP bound enzyme was cleaved by adding TEV protease to 150 nM AuNP 30 µM HCA II
fusion samples. The supernatant was removed using centrifugation as described above. The
AuNP bound N8C GB3 base was kicked off of the nanoparticle by using 5 mM mercapto benzo
imidazole (MBI) and all fractions were run in SDS-PAGE gel. In a similarly prepared AuNPenzyme-bound sample, the TEV protease was added and dialyzed in buffer. The supernatant was
removed after centrifugation and the 4-NPA assay was carried out for the resuspended AuNP
with N8C.
3.3.7

Zeta Potential
Zeta potentials were measured for 15 nm AuNPs, AuNP coated N8C GB3, and equimolar

HCA II fusion and N8C GB3 with AuNP, HCA II fusion enzyme, N8C GB3, and HCA II
protein. All zeta potentials were measured at 25 oC in a reusable 350 µL Omega Cuvette Z
(Anton-Paar). Each zeta potential is an average of 500 scans and the sample solution was
equilibrated in the cuvette for 2 mins before each acquisition.
3.3.8

SERS Measurements
The SERS spectra were acquired using Olympus 10 × objective (NA = 0.25). The He/Ne

laser with an excitation wavelength of 632 nm was used and the laser power before the objective
was 1.3 mW for the SERS acquisition. The spectrograph grating was 600 grooves/mm. The
acquisition times for SERS spectra were varied between 10 and 200 s. The Raman shift was
calibrated with a neon lamp.
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3.4

Results and Discussion
We extensively characterized the fusion protein before it was used in binding capacity

experiments. TheHCA II protein attached to GB3 N8C variant through a linker, was purified by
size exclusion chromatography with, SDS-PAGE gel run for various stages of growth to confirm
the purity of the expressed protein. From the SDS-PAGE gel, pure protein with a molecular
weight of 39.5 kDa was observed with no contaminating bands indicating that N8C GB3, linker,
and HCA II are intact.. The extinction coefficient was measured using previously described
methods and the absorbance measurements were taken using UV-Vis spectroscopy. UV-Vis
spectra were obtained to confirm the non-aggregated state of the protein as well as calculate the
protein concentration using a molar extinction coefficient of 62 500 M-1 cm-1. There was no
scattering observed at 600 nm indicating there was no aggregation of the recombinant protein.
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Figure 3.1

The 1D and 2D NMR spectra of HCA II fusion protein.

(A) The 1D NMR spectra of 50 µM HCA II fusion protein and (B) the overlaid 1H-15N HSQC
spectra of GB3 N8C null fusion (blue), HCA II null fusion (gold), and HCA II fusion protein
(red). Each protein concentration was 100 µM and buffered in 20 mM NaPi (pH 6.5) and 50 mM
NaCl.
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The 15N labeled protein was used to run a 1H-15N HSQC (Figure 3.1B) and the spectrum
looks well dispersed indicating no aggregation. It was overlaid with N8C null fusion and HCA II
spectra in order to compare the chemical shifts of the amide peaks (Figure 3.1). Most of the
amide peaks overlaid and the linker region amino acid residues appear in the middle of the
spectra which predominantly consists of glycine and serine for more mobility. The overlay
indicated that the HCA II and GB3 proteins were in their native confirmation after the fusion.
The binding capacity experiments were carried out as previously studied, 38 where increasing
concentrations of AuNP (20, 40, 60, and 80 nM) were titrated with 20 µM HCA II fusion
protein. The binding capacity was determined to be 110 proteins per AuNP. Importantly, the
number of bound fusion proteins is higher than that of a protein with a comparable size to HCA
II, BCA (29 KDa, 55 proteins per AuNP), and lower than that of the WT base protein, GB3 (6.2
kDa,180 proteins per AuNP). This is indicative of the linker component allowing more HCA II
protein to be adsorbed to the AuNP surface than the non-fusion HCA II protein. The decreased
maximum binding capacity of the fusion protein compared to its GB3 null fusion is due to an
increase in biomolecular crowding in the HCA II layer of the protein corona. The increased
binding capacity of the fusion protein compared to its similarly sized enzymatic homolog is due
to a decrease in biomolecular crowding in the binding layer of the nanoparticle-protein complex.
This binding capacity experiment is an excellent indication that the large fusion protein can stay
attached to the AuNP surface through a base protein.
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Figure 3.2

The UV-Vis spectra of AuNP and product of enzyme attached to AuNP and the
Michaelis-Menton fit when HCA II fusion protein attached to AuNP surface.

(A) The UV-Vis spectra of AuNP at 520 nm and the increasing 4NP UV-Vis signal at 404 nm
while the HCA II fusion is attached to the nanoparticle surface (B) The initial velocities
measured for different substrate concentrations when HCA II fusion protein was on AuNP
surface. The red line indicates the Michaelis-Menton fit. (N=3, using standard deviation)
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For the kinetic studies, the enzymatic function of HCA II fusion was carried out at room
temperature using 4-nitrophenyl acetate as the substrate in pH 7.4 buffer. Using UV-Vis
spectroscopy, the product formation for 3 µM enzyme was measured using UV-Vis spectroscopy
by collecting the absorption spectra in 8-second intervals for 10 min. The Michaelis-Menten
equation was used to fit the resulting velocities of product formation for each substrate
concentration and these fits provide useful information including the Michalis-Menten constant
(Km), maximum velocity (Vmax), a rate constant of product formation (kcat). A control experiment
was carried out with HCA II non-fusion protein to compare the Km, Vmax, and kcat values of the
non-fusion with the HCA II fusion protein. The Km of non-fusion HCA II was determined to be
370.2 µM, whereas HCA II fusion Km was determined to be 384.3 µM. The observed Vmax value
for the non-fusion HCA II protein was 0.083 µM/s, which is slightly higher than what was
observed for the HCA II fusion of 0.076 µM/s. The kcat was determined to be 0.028 s-1 for the
non-fusion HCA II and 0.025 s-1 for the HCA II fusion. A comparison of these parameters (Table
3.1) indicates that HCA II fusion protein activity was not obstructed by the addition of the linker
or base protein GB3. This indicates that even with the addition of a linker and N8C GB3, HCA II
enzymatic function was preserved compared to HCA II non fusion protein.
Table 3.1

Enzyme kinetic parameters

Construct
HCA II
HCA II Fusion
AuNP HCA II Fusion

Km (µM)
370.2 ± 3.187
384.3 ± 2.881
354.3 ± 4.196

Vmax (µM/s)
0.083 ± 0.006
0.076 ± 0.003
0.080 ± 0.004

Kcat (s-1)
0.028 ± 0.001
0.026 ± 0.001
0.030 ± 0.001

The Km, Vmax, and Kcat values of HCA II null fusion, HCA II fusion, AuNP HCA II fusion. The
experimental details are given in material and methods section.
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In order to confirm that the HCA II fusion protein binds to the surface of AuNPs, 30 nM
AuNPs were incubated overnight with 30 µM HCA II fusion protein and washed three times
with buffer after centrifuging each time. After three washes, the pellet was resuspended in buffer
and a 1D 1H NMR spectrum was measured. The spectrum showed no amide or aliphatic signals
indicating that all of the protein was adsorbed to AuNP surface.
The enzymatic activity of the HCA II fusion and HCA II non fusion protein was
measured in the presence of AuNP with the increasing 4-NPA concentration (Figure 3.2A).
Before each experiment, the HCA II fusion was incubated with AuNPs and washed three times
to remove any unbound fusion protein. HCA II non fusion protein did not show enzymatic
activity on the nanoparticle surface. The inhibition of carbonic anhydrase activity was previously
reported due to the structural changes.39 When HCA II fusion was bound to AuNP, the Km, Vmax,
and kcat were found to be 354.3 µM, 0.080 µM/s, and 0.030 s-1 respectively (Figure 3.2B). Even
though the kinetic parameters were slightly lower, the values compared to HCA II non fusion
protein indicated that AuNP-fusion protein was able to retain the enzymatic activity on the AuNP
surface. Comparison of kinetic parameters (Table 3.1) of HCA II non-fusion, HCA II fusion, and
HCA II fusion attached to AuNP, reveals several interesting patterns. First, attaching a GB3
variant using a linker did not affect the enzymatic activity of HCA II. Second, the GB3 base
allowed the HCA II protein to retain its structure while decreasing the effects of molecular
crowding once bound to the AuNP surface. This in turn also aided the HCA II protein in
maintaining its proper orientation so that substrate can reach the active site. Finally, binding the
fusion protein to the AuNP surface did not diminish the enzymatic activity of HCA II. Herein,
we have demonstrated that an enzyme can be functionalized onto the AuNP surface without
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obstructing its activity. The linker and the base protein helped the HCA II maintain its proper
orientation and overcome the biomolecular crowding that would otherwise be present on the
nanoparticle’s surface. Due to the linker, the HCA II active site can easily be accessed by its
substrate. Since HCA II is not directly bound to the surface of the AuNPs, it does not undergo
any structural changes which would hinder its enzymatic activity.
Table 3.2

The zeta potential values for different constructs
Construct
AuNP
AuNP GB3 Null Fusion
AuNP HCA II Fusion:GB3 Null Fusion (50:50)
AuNP HCA II Fusion
GB3 Null Fusion
HCA Null Fusion

ζ (mV)
-57.17
-15.00
-9.63
-8.47
7.53
5.80

±
±
±
±
±
±

σ
0.90
0.37
0.26
0.47
0.21
0.16

The zeta potential measurements for 15 nm AuNP and AuNP coated with different protein
constructs. Null fusion constructs are not fusion protein constructs.
The modulation of enzymatic activity was done by cleaving the HCA II enzyme from the
base N8C GB3 while it was attached to the AuNP surface. After incubating with TEV protease,
the sample was centrifuged, and the supernatant was removed. The pellet was then washed three
times with buffer and tested for any cleaved protein using 1D protein NMR and SDS PAGE gel.
SDS-PAGE gel further confirmed the cleavage of HCA II from the N8C GB3 base on the
nanoparticle. The supernatant and the resuspended pellet with N8C attached to AuNP were
treated with MBI and were observed by SDS-PAGE. This further confirms that HCA II can be
completely removed from the GB3 base, opening avenues for modulating enzymatic activity
using functionalized nanoparticles. The supernatant was suspended in the assay buffer and 4NPA was added, absorbance was observed at 404 nm wavelength. This indicates that the TEV
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cleavage site can be used as a tool for modulating enzymatic activity. This can be further
developed into a means of a drug delivery construct by releasing an enzyme or the drug in the
correct compartment of the body by a cleavage site.

Figure 3.3

The SERS Raman spectra of AuNP in solution and fusion protein bound to AuNP.

The SERS Raman spectra of HCA II fusion protein with (Red) and without (Blue) AuNP stained
with Ag.
The protein attachment to AuNP surface was characterized using zeta potential. 40-42 Zeta
potential was measured for citrate coated 15 nm AuNP, AuNP coated with GB3 null fusion
protein, AuNP coated with 1:1 ratio of GB3 null fusion and HCA II fusion, AuNP coated HCA
II, HCA II, and GB3 null fusion (Table 3.2). Both proteins have characteristic positive charges
(GB3 null fusion 7.53 mV, HCA NF 5.8 mV) while the citrate coated AuNP has a characteristic
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negative charge (-57.17 mV) due to the citrate coating. When any kind of protein is incubated
with AuNPs, the zeta potential decreases indicating protein binding to AuNP surface.41 Our
hypothesis was the zeta potential of 50:50 mixture of HCA II fusion and GB3 null fusion on
AuNP surface will have an average zeta potential values of HCA II fusion and GB3 null fusion
on AuNP surface. A 1:1 mixture of HCA II and GB3 null fusion and HCA II decreased the zeta
potential more than the GB3 null fusion alone. The AuNP zeta potential decreased from -57.17
to -15.00 mV and -8.47 mV when mixed with GB3 NF and HCA NF, respectively. When the
AuNP was coated with a 50:50 mixture of GB3 NF and HCA NF the zeta potential was -9.50
mV. Based on our data, our hypothesis did not hold, and the 50:50 mixture zeta potential was
close to the zeta potential of HCA null fusion on AuNP. We believe this is due to the bulk
electrostatic charge provided by larger proteins. The N8C GB3 variant thiol bond with AuNP
was characterized through SERS Raman (Figure 3.3). The characteristic Au-S bond was detected
at 200 cm-1 for the AuNP-fusion protein compared to AuNP.43 The AuNP-fusion protein was
stained with silver to increase the resolution of the SERS spectrum.
3.5

Conclusion
Herein, we have demonstrated that using a fusion protein can help to functionalize

nanoparticles and mitigate changes to the protein such as orientation, structure, surface
crowding, and loss of enzymatic activity. Our HCA II fusion construct showed undiminished
enzymatic activity when it was bound to AuNP surface. The kinetic parameters for the enzymatic
activity (Vmax, Km, and Kcat) were similar when HCA II fusion was in the presence and absence
of AuNP. We have successfully modulated the enzyme on the AuNP surface using the TEV
cleavage site. This will lead to effective functionalization and modulation of proteins onto
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nanoparticles which can be transported into compartments of the human body by acting as a drug
delivery vector.
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CHAPTER IV
THE ADSORPTION KINETICS OF BIOMOLECULES ON TO PEGYLATED GOLD
NANOPARTICLES
4.1

Abstract
Polyethylene glycol (PEG) surface conjugations are widely employed to render

passivating properties to nanoparticles in biological applications. The benefits of surface
passivation ability of PEG are reduced protein adsorption, diminish non-specific interaction, and
improvement in pharmacokinetics, are widely explored. But sparse discussion is carried out on
the limitations of PEG coating. Herein, we study the adsorption rate of biomolecules with
different size, charge, and surface cysteine content on three different sizes of PEG chains
conjugated to gold nanoparticles (AuNP). The experiments are carried out at physiologically
relevant time periods to obtain the adsorption rates of each biomolecule on different sizes of
PEGylated AuNPs. Our finds are relevant in understanding how the size and the surface cysteine
residues affect the binding and reveal shorter chain PEG molecules passivate the AuNP surface
effectively.
4.2

Introduction
When AuNPs encounter the biological environment, the biomolecules will spontaneously

adsorb to the NP surface. For many biomedical applications, the NP surfaces need to be designed
to elicit the adsorption of biomolecules for bioimaging and biosensing.1 On the other hand, some
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AuNPs surfaces are designed to limit the adsorption of biomolecules to not be recognized by the
human body.2 For example, many AuNP surfaces are used for target drug delivery and need to
pass through the blood-brain barrier or clearance from the immune system. 3-4 When NPs are
administered intravenously,5 AuNPs are rapidly removed from the circulation and accumulate
mainly in the liver and the spleen due to the opsonization and recognition by phagocytes.3,6
There have been many studies to reduce the uptake of AuNPs by modifying the physicochemical
properties of AuNP such as size, surface charge, hydrophilicity, and surface functionality.4,7-11
A well-known method to avoid phagocytosis is PEGylation of NPs. 12-13 There are
numerous studies indicating that PEG-coated AuNPs reduce the protein corona formation and
increase the retention time of the NPs in the blood circulatory system. 14-15 There have been many
experimental studies indicating the passivating effect of PEG on AuNPs is rendered due to
reduced tendency of protein binding to PEGylated surface.16-17 Since the protein corona is not
formed, the immune cells or other targeting systems do not recognize the AuNP.18-19 The
immune system response triggers when the opsonin corona is formed altering the phagocyte
system to rapidly remove the AuNPs from the bloodstream. PEG-coated NPs are widely used as
drug carriers because the solution exposed termini can be modified with a drug.20-23 This
technique has been shown to be effective in cancer cell treatments, where doxorubicin attached
to PEG-coated AuNPs is the most common treatment to target cancer cells. 24
In general, there are numerous variations in PEG-coated NPs due to the PEG molecules
varying in size, terminal modification, and charges. 25-27 PEGylation is conducted using several
unique techniques including detritylating PEG derivatives, covalent attachment, entrapment, or
AuNP surface adsorption of PEG chains. The effect of the PEGylation depends on the PEG
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molecular weight, polymer chain architecture, PEG surface density on the AuNP surface that
lead to the conformational changes of PEG chain on the surface.28-29 These findings are of great
relevance for studying protein adsorption onto PEGylated spherical nanoparticle surfaces. Thus,
the protein adsorption resistance on the NP surfaces can vary drastically depending on the
PEGylation strategy. Previous studies have shown that the PEG-coated AuNP passivates
biomolecules, especially the higher molecular weight PEG providing more resistance to serum
proteins.17 Most of these studies were carried out at shorter incubation periods, under 12 hours,
in which PEG exhibits excellent passivating characteristics. In contrast, some studies have
indicated that biomolecules were able to penetrate the PEG layer, yet a systematic study has not
been carried out to obtain the adsorption rates of different biomolecules on AuNP coated with
different sizes of PEG.30-31 It is important to identify how other biomolecules in the blood
interact with PEG-coated NPs to optimize NP as a drug delivery vector. Our results will give a
spectrum of possibilities to choose from PEG chain lengths or the biomolecules which can
disrupt the PEG layer on the AuNP surface.
The NP surface passivation is not the only effect on PEGylation. Other important
physicochemical properties of NPs are also affected such as size and charge. The most important
property is the change in size as measured as the hydrodynamics diameter. The diameter
increases depending on the PEG chain length and the end terminal modifications. It has been
reported that particle size of more than 50 nm adversely affects cellular intake and toxicity. 32
PEGylation also modifies the surface charge of NPs, even with uncharged PEG molecules. This
effect may result from a reduction of the number of charged groups on the AuNP surface due to
the utilization of the charge as anchoring points for PEG. The other effect is that PEG increases
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the colloidal stability of AuNPs.33 The AuNP colloidal stability will decrease in the presence of
high counter-ions in high salt concentrations. There have been studies indicating PEGylation
assists the colloidal stability of AuNP via steric repulsion, even under high salt concentrations.34
Therefore, in this study, we have quantitatively characterized the biomolecule adsorption
to PEGylated gold nanoparticles. These nanoparticles are coated with 5K, 10K, and 30K thiolate
PEG, which makes a covalent bond with AuNP surface. We have employed NMR to study the
biomolecule adsorption to PEGylated AuNPs and calculated adsorption rates of each
biomolecule onto PEGylated AuNP. We have quantified the AuNP size increase and the surface
charge perturbation through UV-Vis, DLS and zeta potential.
4.3
4.3.1

Material and Methods
Synthesis of Citrate-Stabilized Gold Nanoparticles
15 nm AuNPs were synthesized via citric acid reduction using principles of the Turkevic

synthesis method. Tetrachloroauric Acid (HAuCl4) and sodium citrate dihydrate were purchased
from Sigma-Aldrich. After 100 mL of 0.3 mM HAuCl4 had been heated to boiling, 2 mL of 34
mM sodium citrate solution was immediately mixed with the gold solution. This mixture was
stirred with heat for an additional 20 min before being cooled to room temperature. The cooled
solution was then centrifuged for 45 min at 9000 x g. The concentrated AuNP sample was then
extracted and sonicated for 6 min (in 1-mi intervals) at a power level of 1 on a Branson
sonicator. The sonicated sample was characterized via UV-Visible spectroscopy and
transmission electron microscopy for size and conformity. For 15 nm AuNPs, it was expected
that the maximum absorbance should be at 520 nm.
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4.3.2

Protein Preparation
WT GB3 and its variants were expressed and purified according to previously published

methods. Protein purity was established using SDS-PAGE electrophoresis and the concentration
of all proteins was measured at 280 nm wavelength using UV-Vis spectroscopy. H1.5 peptide
was purchased from GenScript and used after dissolving in an appropriate buffer. GSH and BSA
were purchased from Sigma Aldrich and were used without any further purification.
4.3.3

PEGylated Gold Nanoparticle Preparation
The thiolated 5K, 10K, and 30K poly(ethylene glycol) monomethyl ether (PEG) were

purchased from Laysan Bio, Inc. The PEG-SH were dissolved in MiliQ water for an appropriate
concentration of stock solutions. 120 nM AuNP were incubated with 100 μM of the three
different sizes of PEG to fully saturate the AuNP surface. After the overnight incubation, the
solutions were centrifuged at 9000 x g and washed three times with NaPi buffer to remove any
unbound PEG molecules. After that PEG-coated AuNP were resuspended in NaPi buffer. The
PEGylated AuNPs were measured through UV-Vis spectra to confirm the binding.
4.3.4

NMR Adsorption Capacity Measurements
20 µM protein was prepared with 20 mM phosphate buffer at pH 6.5. After adding 6%

D2O and 200 μM DSS, protein samples were mixed with AuNP at concentration of 120 nM
AuNP. When a protein construct has any thiol groups, 50 mM TECP and pH 6.5 PIPES buffer
was used in the sample preparation. The volumes were adjusted to have a total protein
concentration of protein and DSS concentrations to be the same for all samples. The samples
were incubated for 12, 24, 48, 60, and 72 hours before taking the 1D NMR spectra for GSH,
H1.5, and BSA. 1H-15N HSQC were collected to measure the bound protein concentration WT
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GB3 and its variants. The NMR spectra were recorded at 25 oC using a 600 MHz Bruker Avance
III cryoprobe-equipped NMR spectrometer.
NMR spectra were processed using TOPSPIN 3.1 software. The bound protein
concentration was measured by using the DSS peak as an internal reference and integrating the
protein amide signal with and without AuNP at different time intervals.
4.3.5

Dynamic Light Scattering and Zeta Potential
A Wyatt DynaPro NanoStar DLS instrument was used to measure the NP size

distributions. After equilibration for 1 h at room temperature, the solution was diluted 5-fold
before transferring to a disposable microcuvette for measurement. The nanoparticle hydration
radii were measured using the regularization fit functionality of the DYNAMICS software. For
each measurement (with or without PEG), the average value of three independently prepared
samples is reported and the uncertainty is calculated as the standard error of the mean.
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4.4

Results and Discussion

Figure 4.1

The structures of each biomolecule used in the study.

(A) Glutathione (GSH), (B) a small peptide (H1.5), (C) GB3 protein (GB3), and (D) bovine
serum albumin (BSA) were used to investigate PEG-SH layer permeability.
The AuNP size was confirmed using UV-Vis spectra, DLS (Table 4.1), and TEM.
PEGylated AuNP were monitored using UV-Vis spectroscopy and observed a redshift in the 520
nm peak. This redshift is characteristic of 15 nm AuNP localized plasmon resonance being
disturbed by the PEG adsorption and this trend has been reported for 15 nM PEGylated AuNPs.36
Thiol groups are known to form covalent bonds with AuNP surface. Covalent modes are used to
bind functionalized groups to gold nanoparticle surfaces such as molecules like PEG and protein.
The formation of thiol group enables tight binding on to AuNP surfaces. Once the thiol bond is
formed it prevents the molecule displacing from the surface by making an irreversible bond. The
UV-Vis peak at 520 nm increased to 521, 523, and 523 nm for 5K-PEG-SH, 10K-PEG-SH, and
30K-PEG-SH, respectively (Table 4.1). The hydrodynamic radii measured by the DLS were
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18.4, 27.7, 38.9, and 78.2 nm for AuNP, 5K-PEG-SH, 10K-PEG-SH, and 30K-PEG-SH. It is
hypothesized that when short-chain PEG-SH binds to AuNP it fully saturates the AuNP surface
with minimum spaces in between chains and when the PEG-SH chain length increases it making
the chains more flexible, leaving more spaces in between the chains. 14
Table 4.1

The size, accessible surface cysteine groups, and net charge of each biomolecule
used in the study.
GSH
Size (kDa)
Surface Cysteine
Net Charge

0.3
1
-1

H1.5
(peptide)
1.4
0
5

GB3
(3 variants)
6
0, 1, 2
-2, -3, -3

BSA
66
1
-17

The proteins and peptides were selected to have different sizes and surface thiol groups
(Table 4.1). The biomolecules were GSH, H1.5, WT GB3, GB3 K19C, GB3 K19C T11C, and
BSA. GSH is the smallest construct with only one thiol group. WT GB3 doesn’t contain any
thiol groups (cysteine), but the mutated K19C and K19C T11C have one and two thiol groups
respectively. BSA is the largest protein with only one surface thiol group. All constructs are well
characterized, and UV-Vis spectroscopy was used to measure the concentrations using extinction
coefficients at 280 nm for all the constructs except H1.5 peptide. The concentration of H1.5
peptide was measured using its molar mass. The 20 µM proteins were incubated with PEGylated
AuNP for different time points ranging from 12 hours to 72 hours with a time interval of 12
hours. The 1D NMR spectra were collected to measure the bound protein concentration for each
time point. First, we tested the adsorption of WT GB3 with 5K-PEG-SH coated AuNP. No
observable adsorption occurred during a 72-hour period for 5K-PEG-SH indicating that AuNP
surface was passivated by PEG (Figure 4.2A). 10K-PEG-SH and 30K-PEG-SH were tested with
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WT GB3 to observe adsorption after 60 hours (Figure 4.2A). The penetrated GB3 concentration
was 2 µM both 10K and 30K PEG after 60 hours. We believe that even at higher PEG chain
lengths, small proteins cannot penetrate the PEG layer due to the lack of surface cysteine group.
At long periods of time, a small number of WT GB3 may reside between the PEG chains or have
enough time to penetrate the PEG layer to attach to the AuNP surface through electrostatic
interactions.

Figure 4.2

The WT GB3 and K19C adsorption to PEGylated AuNPs.

(A) WT GB3 adsorption to 10K and 30K PEGylated AuNPs during the 12-72 hour incubation
period. 5K PEGylated AuNP passivated the WT GB3 adsorption. (B) The K19C adsorption to
PEGylated AuNPs during the same time duration and red line indicated the pseudo-first-order
kinetics fit.
We tested K19C, a variant of GB3 containing one thiol group at the 19th position (Figure
4.2B). Proteins with cysteine residues covalently bind to the AuNP surface. Once the covalent
bond is formed, the binding becomes irreversible. The binding capacity of K19C to the three
different types of PEG-coated AuNP was measured using similar techniques as WT GB3. For
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30K PEG-coated nanoparticles were incubated for 12, 15, 18, 21, 24, 48, 60, and 72 hours before
collecting 1D NMR experiments. The data were fitted on to pseudo-first-order kinetics (Figure
4.2B) and 15, 18, and 21 hour time points were not collected in later experiments. Our data
indicate that 12, 24, 48, 60, and 72 hour time points are enough to get the adsorption rates
through pseudo-first-order kinetics (Figure 4.2B). For K19C the initial adsorption to all three
types of PEG started at 12 hour incubation period. All PEG types were able to passivate K19C at
the initial 12 hour period even with the surface cysteine. After 24 hours, 2.9 μM and 5.12 μM
K19C penetrated the 5K-PEG-SH and 10K-PEG-SH layer on the AuNP surface. The 30K-PEGSH recorded the highest concentration of adsorbed K19C at 11.48 μM. The bound concentration
increased with the longer, more flexible PEG chains. This trend followed at 72 hours as well, but
all the PEG-coated AuNP were fully saturated at this point. At longer incubation periods protein
will diffuse on to the AuNP surface and covalently bind to the chains. When comparing similar
size, WT GB3, and its variant K19C, the penetration was due to the thiol group in the protein.
The adsorption rate was 2.3 x 10-5 s-1 for K19C on 5K PEG-coated AuNP, where an adsorption
rate was not determined for WT GB3.
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Figure 4.3

The pseudo-first-order kinetics were fitted onto the unbound concentrations of
different biomolecules onto PEGylated AuNPs.

(A) H.15 peptide (B) GSH (C) K19C (D) BSA adsorption rates on 5K, 10K, and 30K PEG
coated AuNPs during 12-72-hour incubation periods.
Varying the thiol content in similar size proteins were tested to monitor the adsorption
rate and binding concentration. The K19C T11C variant of GB3 (Figure 4.3C), was not able to
penetrate the PEG layer during the first 12 hours. After 24 hours, 3.32 μM and 5.56 μM were
adsorbed to 5K and 10K PEG-coated AuNPs. This is marginally higher than K19C, which could
be due to the two easily accessible thiol groups on the protein surface. However, after 24 hour
incubation period, K19C T11C penetrated all three PEG variants. When compared to the
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adsorption rates of K19C, indicate that for similar size proteins, the adsorption rate does not
depend on the thiol content.
Two smaller molecules, similar in size with and without any thiol groups (GSH and
H1.5), were tested to see if any difference in adsorption was observed in the PEG layer. GSH is a
small peptide with a thiol group at the end with a size of 0.3 kDa, where H1.5 is 1.4 kDa in size
without any thiol group. These two peptides were tested with three different types of PEG over
the same time periods as previous experiments. The highest adsorption rate was observed for the
30K PEG where GSH entered the PEG layer due to its small size and a thiol group. The rate was
2.9 x 10-5 s-1 for GSH, and 1.3 x 10-5 s-1 for H1.5 for 5K PEG. The rate is two times higher than
the H1.5 for 5K PEG, but the adsorption rate for 30K for GSH and H.15 was 6.1 x 10-5 s-1 and
4.3 x 10-5 s-1, respectively. When the PEG chain length increased, the adsorption rate increased
~3 times, indicating H.15 was able to adsorb at a higher rate compared to the lower chain length
PEG. This validates our hypothesis that lower PEG chains can passivate the AuNP surface more
effectively than higher PEG chains.
Then we compared the adsorption rates and capacities of GSH and H1.5 with BSA, a
protein with a size of 66 kDa and one surface thiol group. Compared to GSH and H1.5, BSA is
approximately 60 times larger in size. Previous studies found that BSA was buried inside the
10K PEG layer on AuNP through fluorescence experiments.14,25 Our studies indicate that due to
the size of BSA, only a small concentration of BSA is adsorbed by all three types of PEGylated
AuNP surfaces. The BSA maximum adsorption was recorded for the 30K-PEG. Even though the
adsorbed concentrations are low, the adsorption rates are similar to H1.5. For the 30K-PEG, the
rate for H1.5 and BSA were 4.3 x 10-5 s-1 and 4.6 x 10-5 s-1, respectively. 30K-PEG was the
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PEGylated surface to hold the maximum concentration of BSA observed. We believe this is due
to the BSA having a surface thiol group, whereas the H1.5 lacks a thiol group. The BSA size is a
factor in better passivation from PEG-AuNP, but in longer incubation periods, BSA can
penetrate and bind to the AuNP surface covalently. On the other hand, even without the thiol
group, H1.5 smaller size helped in achieving faster rates to enter all the PEG layers resulting in
similar adsorption rates to BSA. The adsorption rates of larger molecules with thiol groups have
similar adsorption rates to small molecules without any thiol groups. But the adsorbed protein
concentration is lower for higher molecular weight protein.
Table 4.2

Pseudo-first-order rate constants for GSH, H1.5, GB3 (K19C), and BSA with
varying sizes of AuNP-PEG conjugates.
PEG 5K
GSH
H1.5
GB3 (K19C)
BSA

2.9
1.3
2.3
1.3

PEG 10K
(x 10-5 s-1)
4.0
3.0
3.3
3.2

PEG 30K
6.1
4.3
5.3
4.7

In conclusion, biomolecules of different sizes will penetrate the PEG layer over longer
time periods allowing adsorption onto the AuNP surface. Our study indicates that larger PEG
molecules are less effective in passivating biomolecules molecules as observed in the order of
GSH, K19C, H1,5, and K19C (Table 4.2). Larger PEG constructs adopt a “canopy” like structure
at the top leaving voids in between the PEG chains. Due to this canopy-like structure, the surface
density is lesser than the short PEG chains. This phenomenon allows for the biomolecules to
easily penetrated the surface as data indicates. The shorter PEG chains are much effective in
passivating the AuNP surface from biomolecules.
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CHAPTER V
USING NMR SPECTROSCOPY TO MEASURE PROTEIN BINDING CAPACITY ON GOLD
NANOPARTICLES
Reprinted with permission from Perera, Y. Randika, et al. "Using NMR Spectroscopy to
Measure Protein Binding Capacity on Gold Nanoparticles." Journal of Chemical Education
(2020). Copyright (2020) American Chemical Society.
5.1

Abstract
A simple one-dimensional 1H NMR experiment that quantifies protein bound to gold

nanoparticles has been developed for upper-division biochemistry and physical chemistry
students. This laboratory experiment teaches the basics of NMR techniques, which is a highly
effective tool in protein studies and supports students to understand the concepts of NMR
spectroscopy and nanoparticle-protein interactions. Understanding the interactions of gold
nanoparticles (AuNPs) with biological macromolecules is becoming increasingly important as
interest in the clinical use of nanoparticles has been on the rise. Applications in drug delivery,
biosensing, diagnostics, and enhanced imaging are all tangible possibilities with a better
understanding of AuNP-protein interactions. The ability to use AuNPs as biosensors for drug
delivery methods in cellular uptake is dependent on the amount of protein that is able to bind to
the surface of the nanoparticle. This laboratory experiment solidifies concepts such as
quantitative NMR spectroscopy while reinforcing precision laboratory titrations. Students learn
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how 1H proton NMR spectra can be used to measure free protein in solution and protein bound to
AuNPs. A simple formula is used to determine the binding capacity of the nanoparticle. This
analysis helps students to understand the impact of nanoparticle-protein interactions, and it
allows them to conceptualize macromolecular binding using NMR spectroscopy.
5.2

Introduction
Research on nanoparticles has evolved into a major topic in chemistry.1-3 Nanoparticles

have decisively changed the field of medical research, where nanoparticles are used for drug
delivery, biosensing, and imaging.4-5 Among all other materials, gold nanoparticles (AuNPs) are
observed to have lower toxicity when compared to silver, copper, and cobalt nanoparticles when
used in the presence of different cell lines.6-8 The low toxicity of AuNPs, combined with their
tendency to spontaneously adsorb layers of protein to their surface, opens the door to many
medical applications of nanoparticles. Small AuNPs (<10 nm) are known to be toxic when
administered in the human body, and large AuNPs (>100 nm) are too large to be taken up by
mammalian cells;6,9 therefore, AuNPs for biomedical applications typically have diameters
ranging from 15 nm to 100 nm.10
Despite the promise of beneficial applications, nanoparticles have not yet become
common in clinical use, partially because little is known about the mechanisms that cause
proteins and other biomaterials to spontaneously adsorb to the nanoparticle surface. In order to
harness the full potential of nanoparticles, more must be learned about how proteins are able to
bind to AuNPs.11-12 By understanding more about the chemical principles controlling these
interactions, it will be possible to predict more accurately the binding patterns and biological
interactions of loaded nanoparticles when introduced into a living system. 13 Determining the
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quantity of protein that is able to bind to the surface of the AuNPs will allow for a better
approximation of the amount of drug that can adsorb to the nanoparticles as well.
As the field of nanoscience expands, there is an urgency for nanoscience education and
emerging analytical techniques for high school students and undergraduates. Nanochemistry
undergraduate laboratory experiments dedicated to nanoparticle protein interactions are currently
limited in scope.14-22 Most of these have focused on spectroscopic characterization such as UVvis spectroscopy to investigate the plasmonic properties of silver and gold nanoparticles.15,17
There are also relatively few NMR spectroscopy-based undergraduate labs that focus on
proteins.23-27 Of these, most explore protein-small molecule interactions through enzyme
kinetics,25 or small-molecule binding.23-24,26 The most advanced of these undergraduate NMR
experiments provides students with a 13C-, 15N-labeled sample and explores contemporary NMR
assignment strategies in an 11-week course.27 None of these experiments, however, examines
protein binding in the context of nanoparticles. Reported herein are AuNP-based upper-division
undergraduate experimental procedures derived from recent research on quantification of protein
binding to surfaces.28-29 The underlying theories and measurement techniques behind these
experiments are accessible to undergraduate students, and the modules furthermore allow
students to learn cutting-edge methods in quantitative NMR spectroscopy.30 Advanced NMR
methods, such as dark-state exchange spectroscopy,31 can be used to understand protein
interactions on nanoparticles.32 If a deeper study is desired, these approaches could be
incorporated into the lab experiment, along with light scattering and other spectroscopic
measurements.30
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Learning objectives of this experiment include an introduction to both obtaining NMR
spectra and interpreting spectra to understand nanoparticle-protein interactions. The exploration
of NMR techniques and nano-bioscience are relevant for students in introductory biochemistry or
physical chemistry laboratories, and lays out the foundation for characterization of nanoparticle
protein interaction using NMR instrumention.23-24,33 Students are tasked with characterizing the
synthesized AuNPs and predicting the binding capacity (bound protein on one AuNP particle) of
a protein for a particular size of AuNP.
5.3
5.3.1

Experiment
Module 1: Synthesis of 15 nm AuNPs
In the first experiment module of this lab, the citric acid reduction method is used to

synthesize 15 nm gold nanoparticles.34-35 The full experimental procedure for AuNP synthesis is
given in the Supporting Information. Briefly, when preparing AuNPs, 100 mL solution of 1 mM
of gold (III) chloride trihydrate is prepared using mili-Q water and refluxed to its boiling point.
Just as the solution begins to boil, 10 mL of 40 mM of sodium citrate solution is added. The
mixture is allowed to boil for 20 min before being removed from heating. After cooling to room
temperature, the solution is divided into three 50 mL conical tubes and centrifuged at 9,000 rpm
(7,700 rcf) for 45 min at 20 °C. The supernatant is then carefully removed, and the remaining
nanoparticles are pooled and sonicated for 1 min intervals for a total of 6 min.
5.3.2

Module 2: Binding Capacity Measurements
BCA Protein Preparation. Lyophilized bovine carbonic anhydrase (BCA) is a

commercially available metalloenzyme that catalyzes the interconversion between carbon
dioxide and water and dissociate ions of carbonic acid. BCA was re-suspended using MilliQ
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water to prepare an approximate 0.1 g/mL solution that was used without further purification.
The actual concentration of this solution was determined using UV-vis absorbance at 280 nm
using a molar extinction coefficient of 50,420 M-1 cm-1.36
NMR Sample Preparation. All NMR samples were prepared with a total volume of 550
μL to ensure proper filling in a standard 5 mm NMR tube. Each sample was mixed in a 1.5 mL
microcentrifuge tube, and all samples contained 20 μM of BCA, 40 mM phosphate buffer
solution at a pH 6.6, 6% D2O, and 200 µM DSS.37 This can be done using stock solutions of 400
mM sodium phosphate (55 μL), and 5 mM DSS (22 μL), which can be prepared beforehand.
Finally, MilliQ water and AuNPs were added to samples, with increasing concentrations of
AuNPs. As the AuNP concentration was increased, the volume of added water was decreased, so
that the total volume remained fix at 550 μL. AuNPs were always added last, and
microcentrifuge tubes were gently mixed by inversion. The value for the final AuNP
concentration was typically 80 nM, which was prepared by adding a concentrated stock solution
of 200 nM AuNPs. The samples were then left at room temperature for approximately 1 h to
ensure the protein had ample time to bind to the AuNP surface.
Binding Capacity Measurement. 1H NMR analysis was performed on each of the samples
described above. The spectra gathered were then analyzed using the TopSpin software (Bruker
Biospin, Billerica MA; available free of charge at the Bruker website). After phasing, baseline
correction, and normalizing all spectra to the DSS peak intensity, the difference in the intensity
of the peaks in the amide proton region (6-10 ppm) was measured to calculate the amount of free
protein in the samples. Due to the slow rotational diffusion of the nanoparticles, the bound
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proteins were not detected in the NMR spectrum; only the free protein remaining in the samples
resulted in a signal in the amide region.
5.4

Hazards

Students should wear goggles, a lab coat, and gloves throughout the experiment.
Aqua regia (nitric acid and hydrochloric acid) is highly caustic, and particular care should be
exercised when washing glassware. Used aqua regia should be disposed of using the
appropriate regulatory guidelines. A fume hood should be used for heating during the
nanoparticle synthesis. The nanoparticles themselves are not hazardous in this preparation, 38
and they can be handled using standard laboratory chemical safety guidelines.
5.5

Results and Discussion
In the present study, BCA was titrated with increasing concentration of the AuNPs. First,

students successfully synthesized 15 nm AuNPs using citrate reduction method. The size of
AuNPs is correlated to the ratio of sodium citrate to gold chloride used during synthesis. More
concentrated sodium citrate produces smaller AuNPs and vice versa. This is because more citrate
in the solution results in more nuclei formed at the beginning of the AuNP ripening process.
Since the amount of Au3+ precursor is constant, the average AuNP size is decreased with an
increasing number of nuclei. The synthesized 15 nm AuNPs have a maximum plasmonic
absorption peak at 520 nm (Figure 5.1).39-40 Gold chloride (III) is initially yellow in color and
upon addition of sodium citrate, the solution becomes colorless and slowly turns to wine red as
nanoparticles are synthesized (Figure 5.1, inset). The calculated extinction coefficient for 15 nm
AuNP is 3.9 x 108 M-1 cm1 at 520 nm.41 Depending on how much supernatant is removed the
final AuNP concentration can range from 100-200 nM.
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Figure 5.1

Initial synthesis of nanoparticle solutions.

The inset shows the color change observed when AuNPs are synthesized from citric acid and
gold (III) chloride trihydrate. From left to right, the vials are 40 mM sodium citrate, 1 mM
HAuCl4, 2 nM 15 nm AuNPs, 2 nM AuNPs in the presence of 20 µM BCA. The main graph
shows the UV-visible spectra of spherical 15 nm AuNPs in the absence and presence of BCA.
The black curve represents the 15 nm AuNPs without protein at a nanoparticle concentration of 2
nM. The red curve represents the half saturation point when BCA is added, and the blue curve
represents the fully saturated state. The red and blue curves are not collected as part of the
experiment module, but they are shown to support the color change present in the inset.
Once the AuNPs and BCA protein were made properly, the NMR sample preparation was
carried-out according to the steps previously discussed. The UV-vis peak was observed to shift
as proteins and AuNPs were mixed (Figure 5.1). When comparing the 1H NMR spectrum
collected for each sample, it can be seen that, as the nanoparticle concentration increases, the
intensities of the peaks in the amide proton region decrease as protein adsorbs to the nanoparticle
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surface.28,30 An example spectra for BCA is shown for several concentrations of AuNPs in
solution (Figure 5.2A).

Figure 5.2

Student collected 1D NMR spectra of BSA and binding capacity measurement.

(A) Student-collected example of overlaid 1H NMR spectra of BCA as the concentration of 15
nm AuNPs is increased. Amide proton NMR region of BCA in the presence of 0 (black), 20
(red), and 60 (blue) nM AuNPs. The amide peak intensities are reduced as AuNP concentration
is increased, a result of protein binding (B) The concentration of bound protein was plotted
against various concentrations of AuNP and the best-fit line (red) represents the binding capacity
of BCA on 15 nm AuNP.
TopSpin software was used to measure the ratio between the peaks within the amide
region before and after addition of AuNPs. Relative to the sample containing no nanoparticles,
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this ratio (r) represents the fraction of signal remaining in solution after addition of AuNPs.
Since the total concentration of protein is known (𝐶𝑃 ), the free protein concentration is 𝐶𝐹 =
𝑟𝐶𝑃 , and the bound protein concentration is 𝐶𝐵 = (1 − 𝑟)𝐶𝑃 . The binding capacity for BCA is
simply the number of bound BCA molecules per nanoparticle (equation 1):

𝑁𝐵𝐶𝐴 =

𝐶𝐵
𝐶𝑃
= (1 − 𝑟 )
𝐶𝑁𝑃
𝐶𝑁𝑃

(5.1)

where 𝑁𝐵𝐶𝐴 is the binding capacity of the protein (number of BCA molecules per
nanoparticle), and 𝐶𝑁𝑃 is the total concentration of AuNPs (in units of molarity). An alternative
approach is possible if multiple experiments are performed. In this case the binding capacity can
be estimated by measuring the slope of a line when 𝐶𝐵 is plotted against 𝐶𝑁𝑃 (Figure 5.2B). This
approach requires binding to be tight (with a dissociation constant 𝐾𝑑 < 1 μM),28 and no
intercept should be used in the linear fit.
The experimentally-determined binding capacity was then compared to the predicted
number of proteins on the AuNP surface making two assumptions: First, it is assumed that
proteins form a monolayer on the AuNP surfaces, and second, it is assumed that the proteins
remain folded when bound. For BCA, the folded state radius of gyration (𝑅𝐺 ) is 1.7 nm.42
Therefore, one single molecule of BCA is predicted to occlude 𝑆𝐴𝐵𝐶𝐴 = 𝜋𝑅𝐺2 = 9.1 nm2 of
surface area (SA) when bound to a surface. A 15 nm AuNP has a total surface area of 𝑆𝐴𝑁𝑃 =
2
4𝜋𝑅𝑁𝑃
= 707 nm2. Therefore, the number of monolayer, folded BCA molecules predicted to

bind the AuNP surface can be determined using equation 2:28
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𝑁𝐵𝐶𝐴 =

𝑆𝐴𝑁𝑃
𝑅𝑁𝑃 2
= 4(
) = 76
𝑆𝐴𝐵𝐶𝐴
𝑅𝐺

(5.2)

Student generated results for BCA (using several different AuNP concentrations) are
shown in Figure 5.2B. In these experiments, the experimental binding capacity (𝑁𝐵𝐶𝐴 ) was
determined to be 68.
5.6

Assessment of Student Learning Objectives
This upper-division undergraduate experiment was performed as an introductory

biochemistry laboratory experiment to four different sections of students (20 students in the pilot,
along with 16 in two other classes, or 36 students total) in a physical chemistry course. The
learning objectives for this experiment are: (1) Students should gain exposure into the principles
that drive the rapidly expanding field of nanotechnology. (2) Students should understand the
experimental and theoretical background of NMR spectroscopy applied to protein-nanoparticle
binding.
Of the students who participated in this experiment, 85% were able to successfully
synthesize 15 nm AuNPs and calculate the BCA concentration. In addition, 80% of students
were able to determine an accurate theoretical binding capacity for BCA on 15 nm AuNPs.
Eighty percent of students correctly calculated the experimental binding capacity using NMR
spectra, including the calculation of water suppression duration in the pulse program. Ninetyfour percent of the students could correctly describe why a discrepancy might occur between the
theoretical and experimental binding capacity. Student evaluation of the laboratory experiment
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indicated that they felt this topic “engaged their interest” (average of 4.6 “agree” on a Likert
scale of 1-5) and they would “recommend this lab to others” (4.6 out of 5).
This two-part experiment allows students to synthesize nanoparticles as well as to learn
the techniques used for the acquisition and analysis of quantitative NMR spectroscopy results.
This builds on the organic chemistry curriculum by reinforcing that NMR spectroscopy is a
quantitative analytical tool in addition to a method for characterizing reaction products. The
students also have an opportunity to practice basic chemistry skills such as solution preparation
and titrations. Students finish the experiment with an increased knowledge in the field of
nanotechnology, and they understand how different analytical techniques can be valuable when
studying nanoparticle-protein interactions. NMR spectroscopy is a commonly used analytical
tool that is applicable in many different fields of research, and knowledge of NMR spectroscopy
benefits the students as they pursue careers in the sciences. General exposure to nanoparticleprotein interactions also gives students a greater appreciation for the growing field of
nanotechnologies. This experiment therefore provides an opportunity for students to delve into
this exciting topic of research to introduce the possibility of a career in nanotechnology.
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CHAPTER VI
SURFACE BINDING CHARACTERIZATION OF ATLE-R2AB IN BIOFILM FORMATION
6.1

Abstract
Staphylococcal autolysin is an enzyme involved in the hydrolysis of peptidoglycan

contained in cell walls and the adherence of bacterial cell walls to other surfaces in biofilm
formation. It is hypothesized that certain structures of bacterial cell walls serve as receptors for
autolysin repeats, such as the R2ab repeat, which houses unique ligand binding properties that
have been implicated in bacterial attachment to surfaces. Knowledge of the dynamic nature and
binding energetics of R2ab is necessary to better understand its role in biofilm formation. We
investigated R2ab dynamics and behaviors when interacting with biomolecules using NMR
spectroscopy. The R2ab backbone and side chains were assigned using conventional NMR
spectroscopy. Analysis of 15N NMR relaxation experiments reveals that the two domains
maintain a rigid conformation without any no inter-domain motions. R2ab interacted with
fibrinogen, fibronectin and silica nanoparticles (SiNP) which was confirmed through relaxation
experiments. The thermal and chemical denaturation of R2ab reveals moderate thermal stability.
Together, these experiments resulted in a better understanding of how R2ab interacts with
surfaces, potentially leading to new approaches for slowing biofilm formation.

143

6.2

Introduction
Bioﬁlms are multi-cellular, three-dimensional bacterial communities anchored to a

surface. Bacteria within a bioﬁlm are surrounded by extracellular polymeric substances (EPS) 1
that can reduce bacterial exposure to toxic conditions and the host immune system. The
attachment of a biofilm to a surface is a complex process regulated by the diverse characteristics
of the growth medium, the substratum, and the cell surface. An established biofilm structure has
a defined architecture which comprises of microbial cells. The EPS provides an optimal
environment for the exchange of genetic material between the cells. 2 Biofilms have great
influence in public health because of their role in infectious diseases and in a variety of medical
device-related infections. For instance, biofilm can form on medical devices, such as catheters or
implants, which often results in hard to eradicate chronic infections. 1,3-7 These infections have
been observed due to biofilm formation in other biological surfaces such as the teeth, skin, and
urinary tract.8
The most frequent nosocomial pathogens found in medical device-related infections are
S. aureus and S. epidermidis. An extremely high percentage of these isolates are resistant to
methicillin.9-12 In addition to specific antibiotic resistance, staphylococci have non-specific
mechanisms of resistance. These non-specific resistance mechanisms are based on the
acquisition of genetic resistance factors and may be chromosomally or plasmid-encoded, of
which biofilm formation is undoubtedly the most important.
S. epidermidis is an opportunistic pathogen that predominantly infects
immunocompromised individuals such as intravenous drug abusers, AIDS patients, patients
receiving immunosuppressive therapy, and premature newborns. 13-14 In otherwise healthy
patients, S. epidermidis can only cause infection after penetration of the skin or mucous
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membranes arising from trauma, inoculation, or implantation of medical devices. S. epidermidis
is easily introduced as a contaminant during surgical implantation of polymeric devices because
it makes up a significant part of the normal bacterial flora of the human skin and mucous
membranes. The most important factor involved in the pathogenesis of S. epidermidis is the
formation of biofilm causing device-related infections.
Infections involving S. epidermidis, due to bioﬁlms, are very difﬁcult to eradicate, often
leading to prolonged antibiotic therapy or surgical removal of the metallic implants and the
surrounding infected tissue.15 The ability to form a bioﬁlm is recognized as a major virulence
factor of S. epidermidis, and understanding the molecular mechanisms underlying staphylococcal
bioﬁlm formation will aid the development of novel therapeutics. One of the most studied
mechanisms of biofilm formation is autolysin enzyme function on the bacteria cell wall.
Peptidoglycan (PGN) is the main component of bacterial cell walls. 16-18 In gram-positive
bacteria, two common glycoproteins in cell walls are PGN attached wall teichoic acid (WTA)
and membrane-bound lipoteichoic acids (LTA).19 In the bacterial cell wall maintenance, older
PGN units are cleaved and new ones are incorporated. 20` Enzymes that cleave bacterial cell walls
are collectively known as autolysins.21 Autolysins are murine hydrolases, with the most common
one being N-acetylmuramyl-L-alanine amidase.22 The cell separation and cell wall turnover are
the main tasks of autolysin.
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Figure 6.1

The structural design of Atl precursor protein.

Atl consists of propeptide, amidase catalytic domain, R1ab, R2ab, R3ab repeat units, and
glucosaminidase catalytic domain.
Among staphylococcus, the most predominant peptidoglycan hydrolase is Atl.23-24 Atl in
both S. epidermidis and S. aureus are similar in sequence and domain structure.25 Atl from both
species has a single peptide, propeptide, amidase, three repeats, and glucosamindase 26 (Figure
6.1). Amidase and glucosamindase domains are linked by R1, R2, and R3 repeats. When Atl is
proteolytically cleaved, the first two repeats will be attached to amidase (amidase-R1-R2) and
the third one will attach to glucosamindase (R3-glucosamindase). Amidase-R1-R2 binds to the
septum sites of dividing cells. The two repeat sequences are responsible for providing stability
and flexibility for amidase catalytic domain to reach more PGN and increase its enzymatic
efficiency. Studies found that R2ab binds to vitronectin, fibronectin, and fibrinogen. 27 Even
though amidase structure and function have already been studied, 22,28 the behavior and structure
of the repeats domains are not being studied thoroughly. It has been hypothesized that R1 and R2
adhere to cell wall structures by facilitating the movement of amidase catalytic domain.25 Repeat
units are equally important as amidase catalytic domain for S. epidermidis to be biofilm positive.
Sequence analysis of R2ab predicted that it’s divided into a-type and b-type subunits
giving rise to the R2ab.25 Each subunit forms a half-open β-barrel by semicircular four β sheets.
In R2a, β1 and β2 sheets are connected with a large loop and the β5 of R2a and β6 of R2b are
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linked by a small loop. The two subunits are in a similar orientation with a larger interface. The
only short helix is appearing at β11 and β12 of R2b. 25 R2ab two domains belongs to SH3b
family domains.
Therefore, we assigned the backbone chemical shifts of R2ab using NMR spectroscopy.
We have measured the 15N backbone relaxation rates of R2ab to analyze the dynamics in
solution. We have studied the thermal and chemical denaturation of R2ab along with
characterizing binding with fibrinogen, fibronectin, and silica nanoparticles (SiNP) using NMR
spectroscopy.
6.3
6.3.1

Material and Methods
R2ab Expression and Purification
The pET15b containing R2ab plasmid was transformed into E. coli BL21(star) DE3

competent cells (Invitrogen) for expression. The recombinant protein is flagged by three residues
(MGS) at the N-terminus followed by Histidine tag (6xH) residues and a thrombin cleavage site.
The total protein contains 172 amino acids while the thrombin cleaved protein has 152 amino
acids. For protein expression, transformed cells were grown overnight at 37 oC in 50 mL of M9
minimal media. The overnight starter culture was used to inoculate larger 1 L M9 minimal media
to obtain initial OD600 of 0.05. Then it was incubated at 37 oC in a 200-rpm shaker. When the
culture reached 0.5-0.7 OD600 was induced with the addition of 1 mM isopropyl β-D1thiogalactopyronoside (IPTG) and cells harvested after 6 h. Cells were pelleted by
centrifugation for 30 mins at 8000xg and resuspended in lysis buffer (150 mM NaCl, 20 mM
HEPES pH 7.5, and 20 mM Imidazole). Cells were incubated on ice rocker for 30 mins with 1
mg/mL lysozyme. Treated cells were sonicated using Branson Sonicator at power level 6 three
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times with 2 min pulse/1 min rest. The resulting lysate was centrifuged at 18,000xg for 4 mins at
4 oC. R2ab was collected from soluble fraction and purified through 5 mL nickel HisTrap FF
columns (GE Life Sciences) that were pre-equilibrated with wash buffer. The bound protein was
eluted using a 60 mL linear gradient with elution buffer contained 800 mM Imidazole.
Uncleaved protein was quantified and thrombin was added accordingly to the solution and
dialyzed overnight in wash buffer. Thrombin was removed by adding 0.5 mL of benzamidine
sepharose beads (GE Life Sciences) and the solution was centrifuged. The supernatant was run
through a nickel HisTrap FF column to remove the cleavage tag. Purified protein was run
through a gel filtration column (26/600 superdex 75 pg) equilibrated with gel filtration buffer (50
mL NaCl, 20 mM NaPi) and 2% NaN3. The purified R2ab was finally concentrated up to 0.5 mM
and protease inhibitor was added (Roche).
6.3.2

NMR Spectroscopy Assignments
All samples for NMR experiments were prepared in 50 mM NaCl, 20 mM sodium

phosphate (pH 7), 6% D2O, sodium azide, and protease inhibitor. The final protein concentration
was 0.5 mM in total volume of 550 μL. The experiments were collected at 298 K using 600 MHz
Bruker Avance III cryoprobe equipped NMR spectrometer. Following spectra were collected to
assign the backbone chemical shifts, 1H-15N HSQC, 1H-13C HSQC, HNCA29, HNCO30,
CBCANH31, CBCA(CO)NH32. The side-chain chemical shifts were assigned using CARA. Nonuniform sampling (NUS) was used to acquire three-dimensional (3D) NMR spectra33. NMR
spectra were processed with NMRPipe, and the NUS spectra were reconstructed by SMILE
(Sparse Multidimensional Iterative Line Shape Enhanced NUS)34. Processed NMR spectra were
analyzed using Sparky and CARA to assign the backbone and sidechain chemical shifts.
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6.3.3

NMR Relaxation Measurements
The relaxation measurements were collected for 0.5 mM R2ab 15N labeled sample. The

R1 spin-lattice relaxation rates were conducted with relaxation delays of 0, 20, 60, 100, 200, 400,
600, 800, 1200 ms. The R2 data was collected using T1ρ NMR experiments using the relaxation
delays 0, 2, 12, 24, 28, 72, 96, 120, 144 ms. The relaxation rates for both R2 and R1 were
calculated by fitting the decay intensities from 1H-15N HSQC spectra. The heteronuclear {1H} 15

N NOE values were obtained by recording spectra with and without proton presaturation period

(2 s). All the relaxation parameters along with {1H}-15N NOE spectra were collected at 25 oC
using the magnet at Mississippi State University (14.1T). All the relaxation data were acquired
4096 x 1344 (t1xt2) complex points and spectra widths of 2067 Hz and 9615 Hz. The R1 and R2
values were obtained from in house developed scripts. CPMG experiments were carried out with
0, 25, 50, 100, 150, 200, 300, 400, 500, 600, 800 and 1000 ms CPMG time intervals and the
CPMG R2 values were obtained from in-hose developed scripts.
6.3.4

R2ab Interaction with Biomolecules
Fibrinogen was added 1:1 ratio and 1H-15N HSQC spectra were collected with and

without fibrinogen. The NMR samples were in 150 mM NaCl, 20 mM NaPi buffer at pH 7.5.
Similarly, R2ab and fibrinogen 1H-15N HSQC spectra were collected at 4 µM and 15 µM of
fibrinogen concentrations. The 1H-15N HSQCs were compared in the presence and absence of
fibrinogen to observe any chemical shift perturbation and intensity losses. Equimolar
concentrations of fibronectin, amidase, and PGN were mixed with R2ab in above mentioned
buffer and 1H-15N HSQCs were compared in the presence and absence of these biomolecules.
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6.3.5

R2ab Chemical and Thermal Unfolding
ΔGo at varying temperatures in combination with guanidine hydrochloride (GdnHCl)

denaturation agent were measured by Horiba FluoroMax 4 spectrofluorometer with a Quantum
Peltier-based heated/cooled cuvette holder and Microlab dual syringe auto-titrator for all
fluorometer measurements (λex= 280nm, λem=300-400 nm). A Starna cells 1 cm x 1 cm path
length rectangular quartz cuvette with a small magnetic stir bar were used for mixing. Spectra are
the average of a series of 5 scans made at 1-nm intervals, 0.1 second signal integration time, and
5.0 nm entrance and exit slit bandpass which has been corrected relative to an appropriate
baseline scan (buffer plus GdnHCl). R2ab protein concentrations of approximately 8.77x106
µg/mL in 50 mm NaCl 20 mm NaPi were used throughout all denaturation experiments. The
titrant consisted of 6.0-7.0 M GdnHCl with final GdnHCl concentrations measured via an Abbe
refractometer. The auto-titrator was loaded with 5 ml of GdnHCl and programmed for 24
titration steps starting at 0.1 M and ending at a total of 4.0 M GdnHCl. Between titration steps,
the sample was equilibrated with mixing for 300 seconds before the spectra were recorded.
Titrations were completed at five temperatures in triplicate, 15 oC, 20 oC, 25 oC, 30 oC, and 35
o

C. The maximum emission wavelength for R2ab was found to be 343 nm and unfolding curves

for each temperature were generated and fit to a two-state unfolding model. A van’t Hoff plot
was generated and a ΔHVH calculated.
6.4

Results and Discussion
Peptidoglycan is the main component of the bacterial cell wall and the gram-positive cell

wall possesses several cell wall glycopolymers. Two of those glycopolymers are wall teichoic
acid (WTA) and the membrane-bound lipoteichoic acid (LTA). During the cell growth of
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bacteria, the existing PGN should be cleaved and the newly synthesized PGN should be
incorporated. Bacteria carefully maintain this balance through enzymes, and one of the main
enzymes are autolysins. Autolysins are murein hydrolases and, in many cases, N-acetylmuramylL-alanine amidases. In Staphylococcus aureus and Staphylococcus epidermidis, the major
murein hydrolase involved in cell separation is named Atl (AtlA for aureus and AtleE for S.
epidermidis). Herein, we focus on AtlE, which is secreted in a Sec protein-dependent manner as
a bifunctional precursor that is composed of two distinct murein hydrolases, an N-acetylmuramyl-L-alanine amidase (AM), and a glucosaminidase (GL). The Atl amidase of S.
epidermidis is composed of the catalytic AM domain and repeats R1 and R2, each composed of a
and b subunits. R2ab common structural features are based on SH3b family such as RT loop,
distal loop, and n-src loop. In our study, we investigated the dynamic nature of R2ab protein and
interaction with other biomolecules mainly through NMR and other biophysical tools to
understand its structure-function.
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Figure 6.2

Assigned backbone amide chemical shifts and the R2ab structure.

(A) The 1H-15N HSQC spectrum of 0.5 mM 15N labeled R2ab recorded at 298 K at 600 MHz in
6% D2O, 20 mM sodium phosphate buffer, 50 mM NaCl, pH 6.5. (B) The β sheets and the loop
regions are named according to SH3b domain. The PDB entries used for R2ab is 4EPC.
Backbone amide resonance assignments were made for 142 residues out of 149 residues
in the 1H-15N HSQC spectrum (Figure 6.2). The 1H-15N HSQC spectrum of 15N labeled R2ab
was assigned with residues and residue numbers.
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Figure 6.3

15

N relaxation values measured for R2ab at 298 K.

(A). {1H}-15N NOE values (B). R2 values and (C) R1 values at 600 MHz (red circles). In Fig A,
the theoretical maximum NOE at 600 MHz (0.82) is indicated as a dashed line. (Fig A inset)
Residues in R2ab, shaded by the NOE value. Yellow indicates near-maximal NOEs, whereas red
indicates minimal NOE values.
The backbone dynamics of R2ab were obtained in solution by measuring 15N longitudinal
relaxation rates (R1), transverse relaxation rates (R2) and {1H}-15N heteronuclear NOEs (Figure
6.3). The backbone relaxation rates for 141 out of 149 non-proline residues were calculated by
using in-hose developed scripts. The above parameters were obtained from 600 MHz at
Mississippi State University. The average values for R1, R2, and {1H}-15N heteronuclear NOE
were 1.05 s-1, 14.19 s-1, and 0.78.
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NOE data provide insights into the dynamic regions of the protein. R2ab crystal structure
suggested a linker between subunit a and b that could make these subunits tumble independently
in solution, however, the lowest NOE value observed by the residues of linker region is 0.71
indicating rigid nature of linker loop and perhaps no inter-domain motions between to subunits
(Figure 6.2B). NOE data reveled that R2ab subunits tumble together in solution maintaining a
rigid confirmation. N-terminus average NOE dropped to 0.19 compared to the overall average
0.78 reflect highly dynamic nature of N-terminal region. The first loop region in β1 sheet (Figure
6.2B) and parts of RT loop showed a lower NOE of 0.6 indicating higher than average dynamics
for the region. N-src loop (Figure 6.2B) also showed considerable dynamics compared to the
average NOE at lower 0.6 range. After that, the S776 residue of the linker showed NOE of 0.71
indicating that subunits have appreciable dynamics through this residue. Compared to RT loop
on R2a subunit, RT loop of R2b does not show any dynamics due to the formation of a stronger
connection to β2 and distal loop of R2a (Figure 6.2B). In the R2b subunit, the SU loop shows the
largest dip in NOE of 0.44 except the N terminal, indicating a higher dynamic region in a vital
secondary structure unit (Figure 6.1A). N-src loop of R2b also shows NOE of 0.68 indicating
similar dynamics with the R2a counterpart. Parts of the distal loop and starting residues of β 11
(Figure 6.2B) show NOE of 0.73, but no dynamics were observed for distal loop in R2a. This is
mostly because the distal loop of R2a makes hydrogen bonding with RT loop of R2b rendering
both rigid entities confirmed by NOESY data. C-terminus showed NOE of 0.64 but it was not
low as the N-terminus NOE 0.19. Even though R2a and R2b subunits are significantly similar in
structure, R2a subunit secondary structure components did not show dynamics compared to the
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structurally similar R2b subunit, especially the RT loop of R2b. The R1 and R2 followed a similar
trend as NOE.
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Figure 6.4

The R2 value comparison from T1ρ and CPMG NMR experiments.

The R2 values collected from T1ρ and CPMG NMR experiments at 600 MHz. 2H-15N labeled
sample was in 6% D2O, 20 mM sodium phosphate buffer, 50 mM NaCl, pH 6.5.
CPMG data can provide motions occurring at a slow dynamic time scale.35 CPMG data
were fitted into the no chemical exchange model as dispersions were not observed (Figure 6.4).
Both the R2 values from T1ρ experiment and CPMG are in good agreement. The final R2 value
was uniform indicating that two domains are having a rigid confirmation which is in agreement
with our NOE data. The R2 average calculated from CPMG was 16.36 s-1 compared to 14.19 s-1
from T1ρ experiment. Some residues in key loops were experiencing chemical exchange. The
residues showing Rex term are L699, S705, T724, T728, R734, S776, N781, Y800, N801, K810,
G811, N834, G835, and Y843 (Figure 6.4). The L699 and S705 appearing in N terminus β1
sheet show slow time scale motion. T724, T728, and T734 located in RT loop of R2a subunit.
S776 is the residue in linker and N781 located at B6. Y800 and N801 appeared in RT loop of
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R2b showing slow time scale motion. K810 and G811 located at SU loop of the R2b subunit.
N834 and G835 appear in the distal loop of R2b. Y842 located at 310 turns showing slower time
scale motion. Compared to R2a, R2b subunit has more residues with slower time scale residues,
and most of them are appearing in same secondary structure units discovered in relaxation
experiments. This concludes that R2b subunit is more functionally relevant to R2ab than R2a
subunit.
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Figure 6.5

The R2(cpmg) comparison between R2ab in solution and complexed with blood
proteins.

The R2(cpmg) measured at 298 K for R2ab (red), R2ab bound to fibrinogen (blue), and R2ab
bound to fibronectin (black).
R2ab was hypothesized to bind with protein like fibrinogen, fibronectin, and
vitronectin.27 Herein, we characterized R2ab binding with amidase, fibrinogen, fibronectin, and
PGN. Fibronectin was identified to be having interactions with R2ab when 1:0.1 molar ratio of
R2ab and fibronectin was in same solution. No chemical shift perturbation was observed
indicating that no site-specific interactions. But, the signal intensity of R2ab decreased uniformly
without any line broadening indicating complex formation. Fibrinogen was first added in
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equimolar concentrations, which lead to a hydrogel formation and only sidechain residues were
visible in 1H-15N HSQC spectra. The fibrinogen concertation was reduced to 15 µM and 4 µM,
which gave visible 1H-15N HSCQ spectra, with the increasing concentration of fibrinogen, the
signal intensity of R2ab decreases suggesting R2ab binding to fibrinogen. Interesting data was
observed when CPMG experiments were carried out for 4 µM fibrinogen sample (Figure 6.5).
We selected lower concentration (4 µM) of fibrinogen to reduce the effect of crowding on R 2.
The R2 from CPMG increased to 21.72 s-1 compared to the CPMG R2 of 16.88 s-1. This increase
is due to R2ab binding with fibrinogen, increasing the overall tumbling time.
Similarly, fibronectin bound R2ab was subjected to CPMG experiment. The CPMG R 2
value was 20.87 s-1 compared to R2ab in solution (Figure 6.5). There were no chemical shift
perturbations were observed. R2 average increase and signal intensity decrease for both
fibrinogen and fibronectin indicate the complex formation with larger blood proteins which are
related to biofilm formation as well.
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The ΔR2 measured when R2ab interacting with silica nanoparticles.

Cp (kcal/mol°C)

The R2 values were obtained for R2ab in solution and when forming complexes with SiNP.
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Figure 6.7

Thermal denaturation profile using differential scanning calorimetry (DSC).

The protein denaturation temperature (Tm) was calculated using DSC. Red line represents the
two-state fit.
When R2ab and amidase were added in equimolar concentrations, no chemical shift
perturbation or line broadening was observed. Amidase is connected to R2ab through R1ab and
this data suggests that there is no interaction between these two domains of the AtlE protein.
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This confirms that when aligning amidase into cellular LTA there are no interactions between
proteins. There was no chemical shift perturbation observed when PGN was added in equimolar
concentrations to R2ab solution. This suggests that individual entities of amidase and R2ab
won’t attach to PGN, it needs to be linked with amidase, R1ab, and R2ab to perform the
enzymatic activity by attaching to PGN. The overall biomolecule binding experiment indicates
that R2ab binds only with specific proteins. Silica nanoparticles were used to understand the
surface binding behavior of R2ab. In the presence of large molecule (SiNP) exchanging with
small molecule (R2ab) lifetime line broadening occurs.36 When there were not chemical
exchanges were observed, in lifetime line broadening conditions you can assume, ΔR2 can best
represent the exchange regime between R2ab and SiNP (Figure 6.6). The ΔR2 values are uniform
indicates no specific interactions and the adsorption to SiNPs. R2ab surface adherence is
recorded previously for polystyrene, and the SiNP interaction indicates it’s readily attaching with
foreign surface.
The protein denaturation temperature (Tm) was calculated using differential scanning
calorimetry (DSC).37-38 After the two-state fit the change of enthalpy (∆H) was is 24.4 kcal mol-1
(Figure 6.7). The chemical denaturation of R2ab was measured by fluorescence spectroscopy by
using guanidinium chloride as the denaturant.39 The Van’t Hoff plot gave a ∆H of 24.8 kcalmol-1,
which is similar to the enthalpy change observed from DSC.40 The Tm calculated from DSC was
51.2 oC indicating that R2ab is a stable protein, which maintains a rigid conformation in solution.
This was in agreement with our relaxation data, which indicated no interdomain motions. This
further concludes that two subunits are well connected with hydrogen bonding to act as a stable
entity.
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6.5

Conclusion
In conclusion, the structural and relaxation analysis that we present have provided new

insights into how the R2ab domain behaves in solution. Our results also indicate that R2ab binds
with fibrinogen and fibronectin making a hydrogel with fibrinogen at equimolar concentration.
Amidase and PGN do not interact with R2ab as evidence from chemical shift perturbation
experiments. Understanding these surface interactions, such as SiNP, can lead to the prevention
of biofilms on medical devices.
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